Podcasts about diabetes control

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Learning more about the FDA letter sent to Dexcom, news from ATTD including a bihormonal pump from a Dutch company, time in tight range update, more studies about using insulin and GLP-1 medications, eating chili to prevent gestational diabetes (really!) and more..  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Our top story this week: Dexcom Dive Brief: A warning letter posted Tuesday by the Food and Drug Administration revealed quality control issues with Dexcom's continuous glucose monitors. The FDA raised concerns with a design change to a component used in the resistance layer of Dexcom's sensors. The sensors with the new component were less accurate than those with the original component, according to the warning letter. Dexcom has ceased distribution of G7 sensors with the component, but the company's response did not address affected G6 sensors. J.P. Morgan analyst Robbie Marcus wrote in a research note Tuesday that the letter concerns a chemical compound that the sensor wire is dipped in. Dexcom began producing the compound internally to add redundancy to its supply chain.   Dive Insight: Dexcom Chief Operating Officer Jake Leach said in an interview with MedTech Dive last week that the company does not expect the warning letter to affect future product approvals, including a 15-day version of its G7 CGM, and there's no need yet to recall products. Dexcom has submitted the device to the FDA and anticipates a launch in the second half of the year.   Marcus, after speaking to company leadership and a quality control expert, wrote that many of the issues outlined in the letter could be addressed quickly. He added that the warning letter could explain minor delays in approval to the 15-day sensor, but Dexcom is still within the 90-day window for a 510(k) submission.   “While there's always a risk this could impede future product approvals,” Marcus wrote, “we do not expect this to materially delay the 15 day G7 sensor approval.”   The warning letter followed an FDA inspection last year of Dexcom's facilities in San Diego and Mesa, Arizona. Marcus wrote that after the FDA requested additional information and a separate 510(k), Dexcom stopped in-sourcing the compound and reverted back to the external supplier.   Dexcom's devices were misbranded because the company did not submit a premarket notification to the FDA before making major changes to the sensors, according to the warning letter. The sensors with the changed coating “cause higher risks for users who rely on the sensors to dose insulin or make other diabetes treatment decisions,” the letter said.     The FDA raised other concerns in the warning letter, including procedures to monitor the glucose and acetaminophen concentrations used in testing of the G6 and G7 CGMs. The FDA also cited problems with Dexcom's handling last year of a deficiency in its G6 sensors with dissolved oxygen content values, a key input for measuring blood glucose levels. https://www.medtechdive.com/news/dexcom-warning-letter-cgm-coating-change/743597/ XX Lots of studies and info out of the recent ATTD conference. One highlight that has been sort of under the radar: a Dutch company has been using a Bihormonal fully closed-loop system for the treatment of type 1 diabetes in the real world. This is a company called Inreda (in-RAY-duh). The Inreda AP® is an automatic system (closed loop) and independently regulates the blood glucose level by administering insulin and glucagon. The AP5 is certified in Europe and is being used in multiple studies and projects. The AP®6 is currently under development. https://www.inredadiabetic.nl/en/discover-the-ap/ https://pubmed.ncbi.nlm.nih.gov/38443309/ XX Let's talk about time in tight range. If you follow me and diabetes connections on social, you likely saw a video I made about this – it blew up last week. If not.. time in range has been a metric for a short while now.. in 2019 there was a consensus report advising a goal of 70% of time in the 70-180 mg/dL range for most people with type 1 diabetes (T1D) and type 2 diabetes (T2D), with modifications for certain subgroups. Recently we've been hearing more about 70-140 mg/dL — for longer periods as “time in tight range (TiTR).” At ATTD there was more talk about calling that range TING, or “time in normal glycemia.     There's a great writeup that I'll link up from the great Miriam Tucker on Medscape about a debate that happened at ATTD. On March 22, 2025, two endocrinologists debated this question at the Advanced Technologies & Treatments for Diabetes (ATTD) 2025. Anders L. Carlson, MD, medical director of the International Diabetes Center (IDC), Minneapolis, took the positive side, while Jeremy Pettus, MD, assistant professor of medicine at the University of California San Diego, who lives with T1D himself, argued that it's too soon.   https://www.medscape.com/viewarticle/should-time-tight-range-be-primary-diabetes-goal-2025a100073q?form=fpf   XX Sequel Med Tech announces its twist pump will be firs paired with Abbott's FreeStyle Libre 3 Plus. The twist has FDA approval for ages 6 and up and is set to begin its commercial launch by the end of June. The pump—designed by inventor Dean Kamen's Deka Research & Development—also incorporates the FDA-cleared Tidepool Loop software program, to record CGM blood sugar readings, make predictions based on trends and adjust its background insulin levels accordingly. https://www.fiercebiotech.com/medtech/sequel-med-tech-connects-twiist-insulin-pump-abbotts-cgm-ahead-market-debut XX Dexcom's longer-lasting CGM sensor looks promising, based on study results presented at the conference. The trial showed that the new 15-day G7 system is slightly more accurate than the current G7. The accuracy of CGM can be measured using MARD (mean absolute relative difference), which shows the average amount a CGM sensor varies from your actual glucose levels (a lower number is better).  The 15-day G7 has a MARD value of 8.0%, about the same as the Abbott Freestyle Libre 3. The Dexcom G7 15 Day is awaiting FDA approval and is not yet available in the U.S.   XX Little bit of news from Modular Medical.. they plan to submit their patch pump to the FDA late summer or fall of this year. The MODD1 product, a 90-day patch pump, features new microfluidics technology to allow for the low-cost pumping of insulin. Its new intuitive design makes the product simple to use and easier to prescribe. It has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery. Modular Medical picked up FDA clearance for MODD1 in September. The company also raised $8 million to end 2024. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem's t:slim pump. By developing its patented insulin delivery technologies, the company hopes to improve access to glycemic control. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem's t:slim pump. https://www.drugdeliverybusiness.com/modular-medical-announces-12m-private-placement/ XX More from attd – type 2 news? https://www.drugdeliverybusiness.com/biggest-diabetes-tech-news-attd-2025/ XX Another study that says people with type 1 who use a GLP-1 medication get better outcomes. In this study, those who use GLP-1 with insulin are 55% less likely to have a hyperglycemia-related ED visit, 26% less likely to have an amputation-related visit, and 29% less likely to have a diabetic ketoacidosis (DKA)-related ED visit in the following year compared to those on insulin alone. Although they are not approved for T1D, some patients may receive them off-label or for weight control. Pretty big study for an off label drug: compared 7,010 adult patients with T1D who were prescribed GLP-1s and insulin to 304,422 adult patients with T1D who were on insulin alone.  It is important to note that the rates of new diabetic complications in one year for both groups were around 1%, indicating that these are uncommon outcomes regardless of medication use. https://www.epicresearch.org/articles/some-diabetic-complications-less-likely-among-type-1-diabetics-on-glp-1s   XX Early research here but exposure to antibiotics during a key developmental window in infancy may stunt the growth of insulin-producing cells in the pancreas and boost risk of diabetes later in life The study, is published this month in the journal Science, it's a study in mice. These researchers are working off the idea that when while identical twins share DNA that predisposes them to Type 1 diabetes, only one twin usually gets the disease. She explained that human babies are born with a small amount of pancreatic “beta cells,” the only cells in the body that produce insulin.   But some time in a baby's first year, a once-in-a-lifetime surge in beta cell growth occurs.   “If, for whatever reason, we don't undergo this event of expansion and proliferation, that can be a cause of diabetes,” Hill said.   They found that when they gave broad-spectrum antibiotics to mice during a specific window (the human equivalent of about 7 to 12 months of life), the mice developed fewer insulin producing cells, higher blood sugar levels, lower insulin levels and generally worse metabolic function in adulthood.   in other experiments, the scientists gave specific microbes to mice, and found that several they increased their production of beta cells and boosted insulin levels in the blood. When male mice that were genetically predisposed to Type 1 diabetes were colonized with the fungus in infancy, they developed diabetes less than 15% of the time. Males that didn't receive the fungus got diabetes 90% of the time. Even more promising, when researchers gave the fungus to adult mice whose insulin-producing cells had been killed off, those cells regenerated. Hill stresses that she is not “anti-antibiotics.” But she does imagine a day when doctors could give microbe-based drugs or supplements alongside antibiotics to replace the metabolism-supporting bugs they inadvertently kill.   .   “Historically we have interpreted germs as something we want to avoid, but we probably have way more beneficial microbes than pathogens,” she said. “By harnessing their power, we can do a lot to benefit human health.”     https://www.eurekalert.org/news-releases/1078112 XX Future watch for something called BeaGL - created by researchers at the University of California Davis and UC Davis Health who were inspired by their own personal experiences with managing T1D.   BeaGL is designed to work with CGMs and has security-focused machine learning algorithms to make predictive alerts about anticipated glucose changes, which are sent to a device. In this case, a smartwatch. The end goal is for BeaGL to be completely automated to reduce the cognitive load on the patient, particularly for teens. It's still in research phase but six student with T1D have been using it for almost a year.     https://health.ucdavis.edu/news/headlines/with-ai-a-new-metabolic-watchdog-takes-diabetes-care-from-burden-to-balance/2025/02 XX Investigators are searching for a way forward after two long-term diabetes programs were terminated following the cancellation of their National Institutes of Health (NIH) funding, the result of federal allegations that study coordinator Columbia University had inappropriately handled antisemitism on campus. The programs include the three-decades-old Diabetes Prevention Program (DPP) and its offshoot, the Diabetes Prevention Program Outcomes Study (DPPOS). “We are reeling,” said David Nathan, MD, a previous chair of both the DPP and the DPPOS and an original leader of the landmark Diabetes Control and Complications Trial. Nathan is also founder of the Massachusetts General Hospital Diabetes Center in Boston, one of the 30 DPPOS sites in 21 states. On March 7, the Trump administration cancelled $400 million in awards to Columbia University from various federal agencies. While Columbia University agreed on March 21 to changes in policies and procedures to respond to the Trump administration's charges, in the hopes that the funding would be restored, DPPOS Principal Investigator Jose Luchsinger, MD, told Medscape Medical News that as of press time, the study was still cancelled. https://www.medscape.com/viewarticle/diabetes-prevention-program-cancellation-colossal-waste-2025a100076h XX XX Type 2 diabetes may quietly alter the brain in ways that mimic early Alzheimer's. This was only an animal study – but researchers say the high comorbidity of type 2 diabetes (T2D) with psychiatric or neurodegenerative disorders points to a need for understanding what links these diseases.   https://scitechdaily.com/how-diabetes-quietly-rewires-the-brains-reward-and-memory-system/ XX Eating chili once a month when you're pregnant seems to lower the risk of developing gestational diabetes. This is a real study! While chili showed a link to lower gestational diabetes risk, dried beans and bean soup had no significant effect, even among women who ate them more frequently. Some studies suggest that diets high in beans and legumes, including the Mediterranean diet, reduce GDM risk. While studies link beans to lower diabetes risk, their specific impact on GDM remains unclear. This study analyzed data from 1,397 U.S. pregnant women who participated in the Infant Feeding Practices Study II, conducted between 2005 and 2007. Chili consumption varied significantly by race, education, household size, income, supplemental nutrition status, and region. Non-Hispanic Black mothers consumed the most (0.33 cups/week), while those with higher income and education levels consumed less. Regional differences also influenced chili intake. One possible mechanism for chili's effect is capsaicin, a bioactive compound found in chili peppers, which has been linked to metabolic benefits in other studies. However, further research is needed to confirm this potential role in GDM prevention. Dried bean and bean soup consumption had no clear association with GDM. The study highlights limitations due to self-reported dietary data and the need for more detailed dietary measures. https://www.news-medical.net/news/20250317/Could-a-little-spice-in-your-diet-prevent-gestational-diabetes.aspx XX

Send us a textBethany McKenzie was thrust into the world of type one diabetes when her son was diagnosed with the disease in 2015. She discovered this when Bethany came back from a trip, when she noticed her son, River,  had lost weight, dropping from 46 to 40 lbs. Immediately, she rushed him to the hospital, and he was diagnosed. For several years, Bethany followed their rules, only to find that her son felt truly terrible and unhealthy, experiencing headaches, and high blood sugar.Eventually, she realized that she would have to change the way that her family ate, despite the advice from her doctors and dieticians. Bethany found low-carbohydrate diets that have, with careful control, worked wonders for her son and for her family.She is the executive producer of the incredible documentary “The Diabetes Solution”, modeled after the work of Dr. Richard Bernstein in the field of diabetes and insulin.She is also the founder of Let Me Be 83, a movement by the Rivere Foundation. They advocate for an alternative diabetes management regimen, anchored in nutrition and the proper use of insulins, that allows people with diabetes to achieve healthy blood glucose levels. Find Bethany at-FB- @Let Me Be 83https://letmebe83.org/about/Find Boundless Body at- myboundlessbody.com Book a session with us here!

Send us a textUnlock the secrets to managing diabetes through the power of exercise and nutrition with our esteemed guest, Terry Linde, a veteran in the fitness industry with over three decades of expertise. Terry shares his journey and the inspiring story of a client whose life was transformed by incorporating movement into their daily routine. Whether it's a brisk walk or a bit of gardening, Terry emphasizes that keeping active is achievable and beneficial for everyone, particularly for those managing diabetes. This episode promises to equip you with practical strategies to weave exercise seamlessly into your lifestyle, ensuring it becomes a sustainable and enjoyable habit.We also shed light on the critical role of continuous glucose monitors in understanding blood sugar fluctuations and how our tailored program, Conquer Diabetes, is designed to empower individuals through customized fitness and nutrition plans. Our conversation is packed with insights on personalizing fitness routines to accommodate individual needs, focusing on early intervention for pre-diabetes, especially within the Hispanic community. With Terry's expert guidance, discover the balance of strength training and cardiovascular activities that can reduce insulin resistance, enhance overall health, and improve quality of life and longevity. Join us for an enlightening discussion that aims to inspire and support your journey towards better diabetes management.Terry's Conquer Diabetes Program Thank you for listening. Please subscribe to this podcast and share with a friend. If you would like to know more about my services, please message at fueledbyleo@gmail.comMy YouTube Channel https://www.youtube.com/channel/UC0SqBP44jMNYSzlcJjOKJdg

If you'd like to see how I can help you have better control of your Diabetes Apply to work with me here Please remember to hit subscribe and leave me a rating and review if you enjoy this episode ;) Also screen shot and share it on your stories and social profiles as this really helps me reach and help more Type 1 Diabetics. You can reach out to me at ... INSTAGRAM: @type1_tom FACEBOOK: Type1Tom Email: Tom@type1tom.co.uk Download my FREE ebook: https://tafitness.activehosted.com/f/13 Join my FREE FB community: https://www.facebook.com/groups/505161143554884/?ref=share

Join us as Mike and Jack dive into their weekly wins and struggles, with Mike sharing his ambitions to create social media content and Jack rediscovering his love for art and graffiti. They also discuss the challenges of maintaining motivation and the impact of the summer heat on their daily lives. In a candid conversation, the hosts open up about their recent hypo experiences, highlighting the importance of treating lows and the support they receive from loved ones. Mike shares a particularly challenging hypo episode at work, while Jack recounts a frightening morning hypo that left him feeling drained and disoriented. On a lighter note, the episode features listener wins, including the incredible achievement of Marcus and Lisa from Step by Step the Jog, who walked from Land's End to John O'Groats, raising over £5,555 for Diabetes UK. 00:00 - Welcome back 01:11 - Wins & Struggles 08:28 - Going to London 10:22 - Yo, what is your average, bruv 13:00 - Food and London 21:20 - Do you pre bolus for food or don't you do it 23:22 - Jacks Hypo Horror 30:25 - Mikes Hypo at Work 36:05 - Listener Wins Join the conversation and share your stories with the T1D community. Don't forget to rate, review, and subscribe/follow to help others find the podcast. Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Share your stories at https://wearet1d.com   New episodes are released every Sunday & Wednesday PS. If you would like to be a guest on the podcast, please go to the website https://wearet1d.com/guest-booking and fill out the form. Also, don't forget to vote for us in the British Podcast Awards! Your support means the world to us. Visit https://www.britishpodcastawards.com/voting, search for "We Are T1D," and cast your vote. Thank you!  

Mike and Jack kick off with some classic banter, including a surprise intro from Mike's son, Riley, who hilariously takes over his dad's hosting duties. The episode dives straight into their weekly wins and struggles. Jack shares his triumphant hospital appointment, where his dietitian praised his tight glucose control and even noted the podcast's global success in his medical records. Mike, on the other hand, celebrates no more early shifts at work, allowing him to live a more "normal" life with fewer hypos. They also discuss their food adventures, including Jack's homemade burgers and Mike's bacon sandwich feast on Father's Day. Jack even gets inspired to try a fried slice and egg for the first time since diagnosis. The lads share some laughs over their quirky eating habits, like Jack's love for sausages without the roll. The episode takes a deeper turn as they discuss the importance of sleep for diabetes management and Jack's struggle with insomnia. They also touch on the significance of maintaining a positive mindset and how it affects their diabetes control. Also spoke about is James Norton's CBeebies Story and Inside Out 2 mishaps lol. Listener engagement is at an all-time high, with shoutouts to Barnaby for making the Great Britain baseball team and Last of the Diabenders for managing hypo-induced anger. The lads read out more listener wins, including Melissa Lindstead's fearless pizza indulgence and Megan's love for the bonus episodes. As always, the episode is filled with laughs, relatable moments, and valuable insights into living with Type 1 Diabetes. Join the conversation and share your stories with the T1D community. Don't forget to rate, review, and subscribe to help others find the podcast. Follow The Podcast https://www.instagram.com/wearet1d Follow Mike https://www.instagram.com/t1d_mike Follow Jack https://www.instagram.com/t1d_jack Share your stories at https://wearet1d.com New episodes are released every Sunday & Wednesday   PS. If you would like to be a Guest on the podcast, please go to the website https://wearet1d.com and fill out the form.  

In this heartwarming and eye-opening episode of We Are T1D: Type 1 Diabetes, hosts Mike and Jack welcome Sammi, a Type 1 warrior from the Chicago suburbs, for a cross-continental chat that's as enlightening as it is entertaining. Sammi shares her journey from a soccer-playing teen to a T1D powerhouse, revealing the ups and downs of managing diabetes amidst a whirlwind of hormonal changes, including the challenges and triumphs of pregnancy with T1D. The trio dives deep into the complexities of diabetes management, from the fear of lows to the intricacies of insulin pump therapy. Sammi, with her omnipod and Dexcom in tow, provides invaluable insights into the world of automated insulin delivery and the learning curve that comes with it. The conversation takes a turn from the serious to the squirrely as Sammi recounts her struggle with unwelcome furry mechanics in her car. Listeners are invited to join the "wins of the week" celebration, with Mike's pre-bolusing success and Sammi's impressive in-range achievements. But it's not just about the blood sugar victories; the episode also explores the importance of asking for help, the impact of diabetes on relationships, and the power of community support. From gym fears to the financial strains of healthcare in America, this episode covers it all, including a discussion about how different exercises impact blood sugar and the benefits of a protein-rich diet. Mike, Jack, and Sammi keep it real, sharing laughs, personal anecdotes, and even a few tech troubles, reminding us all that life with T1D is unpredictable but manageable with the right mindset. - Follow The Podcast https://www.instagram.com/wearet1d - Follow Mike https://www.instagram.com/t1d_mike - Follow Jack https://www.instagram.com/t1d_jack - Follow Sammi https://www.instagram.com/type1samfit - Share your story and join the community at https://wearet1d.com Don't miss out on this episode's blend of humor, honesty, and heartfelt advice. Subscribe/Follow, Rate, and Review to support the show and connect with the T1D family. Embrace the journey, take the highs with the lows, and tune in for a dose of camaraderie and encouragement. Catch you on the flip side! Stay connected, stay informed, and keep living boldly with Type 1 Diabetes.

In this episode, Charmaine, a seasoned dietitian, and Ghalia, an expert coach in the Reversing Diabetes Program, unravel the complexities of managing diabetes in the digital age. Navigating through the overwhelming and often conflicting information online, they shed light on macronutrients and how you can sequence and balance your meals for better blood sugars! Join the journey as they define macronutrients, delve into the impact of combining macronutrients on blood sugars, and the power of sequencing your foods for better post-meal blood sugars! Learn the science behind the impact and feel empowered by your new-found knowledge!If you're seeking clarity on diabetes management and strategies that you can easily implement to see immediate benefit, then this episode is for you!⇰FREE WEBINAR TRAINING & OTHER LINKS: https://stan.store/reversingdiabetesrevolutionMy name is Charmaine and I'm the registered dietitian who helps people reverse Type 2 Diabetes with plant-based eating.⧫CATCH ME ON:Instagram: @ReversingDiabetesRevolutionTik Tok: @ReversingDiabetesRVLTNYoutube: https://www.youtube.com/c/CharmaineDomingue?sub_confirmation=1Facebook Reversing Diabetes Community: https://www.facebook.com/groups/680396812519649.Sources:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471836/

4:00) - Most Interesting | 126. Amputees Feel Warmth In Their Missing Hand(8:40) - Listener Favorite | 118. Robotics & AI in Sheet Metal Forming(12:23) - Most Impactful | 112. Bringing Humans Back Into The Loop For AI(16:30) - Hidden Gem(s) | 135. Reinventing Retail in The Connectivity Age & 144. An implantable device could enable injection-free control of diabetes

(0:50) - An implantable device could enable injection-free control of diabetes

Don't Let Diabetes Control Your Life || Killerwinds Podcast Cole and Nick talk about Nick's Journey with diabetes and some of the things they look forward to in the upcoming months.Follow Us On Social Media:Facebook - https://www.facebook.com/OzonicsHunting/ Instagram - https://www.instagram.com/ozonicshunting/?hl=en Twitter - https://twitter.com/OzonicsHunting Linked In - https://www.linkedin.com/company/ozonics-hunting  Go To Our Website:https://ozonicshunting.com

It's In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new insulin pump gets FDA approval, once-weekly basal insulin for type 2 gets through another trial, New Jersey caps insulin prices for some, possible link between ability to chew and glucose control, a landmark diabetes study moves on to aging and T1D, JDRF Children's Congress and more! Learn about Moms' Night Out - a new event for moms of children with diabetes Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines happening now XX In the news is brought to you by AG1. AG1 helps you build your health, foundation first. XX Our top story, Tandem's Mobi Pump is approved. The FDA cleared the tiny pump for people with diabetes ages six and up. Tandem says mobie is fully controllable from a mobile app and is the world's smallest durable AID system. It still has a button on the pump to dose and holds 200 units. You use the same infusion set as the current Tandem pumps and Mobi uses Control IQ. Limited release planned for late this year and fully available early 2024. https://www.drugdeliverybusiness.com/fda-clears-tandem-mobi-automated-insulin-pump/ XX Learning more about a newly approved therapy for type 1 diabetes called Lantidra. Two safety and efficacy studies found that 21 participants who took Lantidra did not need to administer themselves insulin for a year or more. Twelve of those participants did not need to take insulin for up to 5 years, and 9 did not need insulin for over 5 years. Lantidra is an allogeneic (donor) pancreatic islet cellular therapy. In other words, Lantidra uses cells taken — or isolated — from human organ donor pancreases. “In [a] subsequent process, the insulin-producing islets are purified from the rest of the pancreatic tissue using a density gradient. Once the islets are isolated, purified, and put for a short time in cell culture, the cell preparation is infused into the liver of the recipient,” he explained. https://www.medicalnewstoday.com/articles/fda-approves-first-cellular-therapy-for-type-1-diabetes-what-does-it-do#How-does-islet-cellular-therapy-work? XX Once weekly basal insulin for type 2 gets through another trial. After 26 weeks of treatment and five weeks of follow-up, patients on weekly insulin icodec had significantly larger improvements in their HbA1C than those using daily insulin. Both groups had an extremely low rate of adverse events. These researches say next step is FDA evaluation. https://www.utsouthwestern.edu/newsroom/articles/year-2023/july-weekly-insulin-found-safe.html XX That's the idea behind Fractyl Health's treatment for type 2 diabetes—which could also be used for weight control. The Lexington, Massachusetts-based biotech company is in the early stages of developing a one-time gene therapy intended to lower blood sugar and body weight using the same mechanism as semaglutide. “You have this problem where you need to stay on therapy for efficacy,” says Harith Rajagopalan, a cardiologist by training and CEO and cofounder of Fractyl Health. “That's the Achilles heel.” The company wants to deliver an artificial gene to the pancreas that continuously produces the GLP-1 hormone so there's no need for weekly injections. The approach, called gene therapy, uses inactivated viruses to carry a therapeutic gene to pancreatic cells. (Viruses are used because of their natural ability to deliver genetic material to cells.) The company is aiming to begin an initial human trial by the end of 2024 https://www.wired.com/story/a-one-time-shot-for-type-2-diabetes-a-biotech-company-is-on-it/ XX Gov. Phil Murphy signed three bills into law Monday aimed at cutting the high cost of prescription drugs in New Jersey. The new laws will cap how much residents will pay for some popular medications such as insulin, prevent pharmacy benefit managers from engaging in practices that make drugs more expensive, and create a panel that will monitor prices set by pharmaceutical companies. One measure (S1614) would cap the cost of insulin, epinephrine auto-injector devices and asthma inhalers for state and local public workers enrolled in the State Health Benefits Program, the School Employees' Health Benefits Program and other state-regulated plans. For a 30-day supply, insulin will cost $35, EpiPens $25 and asthma inhalers would be capped at $50, according to the bill. The law takes effect next year. https://www.nj.com/politics/2023/07/new-laws-to-stem-high-cost-of-prescription-drugs-in-nj-were-just-signed-by-gov-murphy.html XX The European Medicines Agency (EMA) said on Tuesday it has extended its probe into Novo Nordisk's (NOVOb.CO) diabetes drugs Ozempic and weight-loss treatment Saxenda, following two reports of suicidal thoughts, to include other drugs in the same class. The agency began its review on July 3 after Iceland's health regulator flagged the reports of patients thinking about suicide and one case of thoughts of self harm after use of Novo's drugs. https://www.reuters.com/business/healthcare-pharmaceuticals/eu-extends-ozempic-probe-include-other-drugs-2023-07-11/ XX We often hear that diabetes can lead to problems with your teeth.. but one researcher says it might be the other way around. A University at Buffalo researchers says there is a notable correlation between chewing functionality and blood glucose levels in people with type 2. Specifically, he found that patients with T2D who maintain a full chewing ability exhibit significantly lower blood glucose levels compared to those with compromised chewing function. The thinking here is that chewing stimulates the body in all sorts of ways, including releasing hormones that help you feel fuller and help in digestion. More studies are expected. DOI: 10.1371/journal.pone.0284319 https://scitechdaily.com/the-surprising-connection-between-chewing-and-type-2-diabetes/ XX The next step of the landmark Diabetes Control and Complications Trial will focus on aging with type 1 diabetes. The original randomized DCCT clinical trial results, published September 30, 1993, in the New England Journal of Medicine, proved that early intensive glycemic control was the key to preventing or slowing the progression of long-term eye, kidney, and nerve complications of type 1 diabetes. Subsequently, EDIC has yielded many more major findings including that early tight glycemic control also reduces cardiovascular risk and prolongs survival in type 1 diabetes. subsequent EDIC data also have suggested that it is never too late to initiate intensive glycemic control Together, DCCT and EDIC — both funded by the National Institutes of Health at 27 sites in the United States and Canada — have changed the standard of care for people with type 1 diabetes Prior to the DCCT, between 1930 and 1970, about a third of people with type 1 diabetes developed vision loss and one in five experienced kidney failure and/or myocardial infarction. Stroke and amputation were also common, DCCT/EDIC chair David M. Nathan, MD, said while introducing the symposium. "All of the advances in care of type 1 diabetes have developed because this study demonstrated that it was important — continuous glucose monitoring (CGM), new insulins, better [insulin] pumps…I think the most profound finding is that mortality in our intensively treated cohort is the same as in the general population. That says it all," Nathan told Medscape Medical News. https://www.medscape.com/viewarticle/994221 XX Commercial – AG1 XX Today, JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, urged members of the Senate Appropriations Committee to renew the Special Diabetes Program (SDP) and support policies to ensure insulin is available at an affordable and predictable price. Opened by U.S. Senator Patty Murray (D-WA) and led by U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH), the hearing took place during the 2023 JDRF Children's Congress, a biennial event that brings over 160 kids and teens living with T1D face-to-face with lawmakers and top decision-makers. The youth delegates traveled to Washington, D.C. from across the country and JDRF's international affiliates in the United Kingdom, Australia, the Netherlands, and Canada. The SDP has accelerated the pace of T1D research through a long-term investment of funding at the National Institutes of Health. The program has led to significant scientific breakthroughs, including Tzield, the first disease-modifying treatment for T1D, which can delay the onset of the disease by over two years. Without Congressional action, the SDP will expire at the end of September. "The Special Diabetes Program has fundamentally changed what it means to live with diabetes, put new life-changing therapies in our hands, and brought us closer to cures," said Aaron Kowalski, Ph.D., JDRF CEO. "We must keep this momentum going so we can capitalize on the progress to date and realize cures. However, until we have cures, people need access to affordable insulin. JDRF urges Congress to pass the bipartisan INSULIN Act of 2023, which will establish a $35 per month insulin copay cap for people with commercial insurance and includes other provisions that would make insulin more affordable for everyone, regardless of insurance status." Dr. Kowalski was joined at the hearing by Dr. Griffin Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health, who provided testimony on the scientific value of the SDP, and Jimmy Jam, award-winning producer, songwriter, musician, member of the Rock & Roll Hall of Fame, and T1D parent. "My son Max, who is now in his twenties, was just two years old when he was first diagnosed with type 1 diabetes. Late nights working on music became late nights working on music and waking up my son to test and manage his blood sugar levels," said Jimmy Jam. "Type 1 diabetes should be one of those things we can all agree on. Diabetes doesn't care if you're a Democrat or a Republican. We can all agree that there should be research to improve the lives of those with diabetes. We can all agree that insulin should be affordable for all who need it." Two 2023 JDRF Children's Congress delegates shared their T1D experience with the committee: Maria Muayad: 10-year-old Maria is from Maine and is a member of her school's civil rights club and math challenge group. Every November, Maria, and her mother, Golsin, give blue ribbons to the staff at her school in honor of National Diabetes Awareness Month. Elise Cataldo: 15-year-old Elise lives in New Hampshire and is passionate about educating those around her about life with T1D and tries to use things like pump site changes and blood sugar checks as opportunities to help others learn. Following the hearing, the 2023 JDRF Children's Congress delegates continued their advocacy by meeting with lawmakers in their Capitol Hill offices. https://www.prnewswire.com/news-releases/2023-jdrf-childrens-congress-delegates-urge-lawmakers-to-support-type-1-diabetes-research-and-access-to-affordable-insulin-301874927.htmlXX XX A 23-year-old with type 1 diabetes has broken the record for circumnavigating Britain in a kayak after paddling 2,000 miles in 40 days. Dougal Glaisher beat the previous record by 27 days. Glaisher was diagnosed with type 1 diabetes at the age of 19 shortly after winning the Oban Sea Kayak race in Scotland, when he had blurred vision and struggled to recover his energy. The expedition was to raise money for the UK-based charity Action4Diabetes and Glaisher livestreamed his blood sugar On Tuesday he was well stocked with a bunch of bananas and a stash of cereal bars lashed to his boat. But in remote areas it was more challenging. Around the islands off Scotland he ran out of freeze-dried meals and survived on porridge for several days. He also sourced drinking water from streams. . It is the first time anyone has used a surfski – a kayak that you sit on top of – to paddle around the country. XX On the podcast next week.. I sat down with Dexcom's new Chief Commercial officer to talk about their announcements from this week about the type 2 market and other features important to people with type 1. Our last epoisde is all about Kickass Healthy LADA That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

TAKING CONTROL OF YOUR DIABETES® – THE PODCAST! ...With Expert Endocrinologists Living with T1D, Drs. Steven V. Edelman & Jeremy PettusThe Facts About Diabetes ComplicationsDiscussing diabetes complications can be a scary conversation, but it really doesn't have to be. We're sitting down to straighten out the misconceptions about diabetes complications including the difference between severe and consistent hyperglycemia and occasional highs, and the stigma around having symptoms of complications. We'll also discuss how a diabetes diagnosis can be an opportunity to improve your overall health and live a long, healthy life.Questions We'll Cover in This Episode: What is the Diabetes Control and Complications Trial (DCCT) and why is it important? What are misconceptions about diabetes and complications? How long do my blood sugars have to be high before I get complications? How can I see my diabetes as an opportunity for good health? Why is there a stigma around diabetes complications? What are the different types of diabetes complications? Why is 7% the recommended A1c? Am I doomed if I already have symptoms of complications? Type 1 Kidney and Heart Care: https://tcoyd.org/vv-t1d-cardio-kidney/Type 1 Eye Care: https://tcoyd.org/vv-t1d-eye-health/Type 2 Kidney and Heart Care: https://tcoyd.org/vv-t2d-cardio-kidney/Type 2 Eye Care: https://tcoyd.org/vv-t2d-eye-health/ ★ Support this podcast ★

Today, we have the pleasure of introducing our special guest, Elaina Wang, a certified nutrition coach who has an incredible story of reclaiming her health from chronic illness. Elaina's journey is nothing short of inspiring, and she has dedicated her life to advocating for and assisting others in discovering the transformative power of the Ketogenic way of life.In this episode, Elaina shares her personal transformation story, from battling chronic illness to finding a path towards optimal health. Elaina's passion for helping others shines through as she discusses her journey into coaching. On this Episode: Introduction to Elaina Wang2:24 Conquering Childhood Obesity, Chronic Illness, and Addiction4:41 Unraveling Epstein Bar Syndrome6:53 Path from Emotional Eating to Empowered Transformation19:49 Exploring the Role of Hypnosis in Addiction9:04 Confronting Early-Onset Diabetes10:50 Finding Hope in the Face of Addiction and Diabetes19:41 Choosing Sobriety: Elaina Wang's Inspiring Path to Recovery21:46 Ketogenic diet for Diabetes Control33:30 From Personal Growth to Empowering OthersShow Links:Link to Elaina Wang's bio:My website: People can contact me through my website.Call to action for listeners: Follow ketones and Coffee Podcast on Instagram ( https://www.instagram.com/keton.esncoffee ), Youtube ( https://www.youtube.com/channel/UCsZZmBEenvZnU8tA1npAODA ), and Twitter ( https://twitter.com/KetonesP ) for updates and new episodes.~~~~~~Estrella by Audiorezout is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License.~~~~~~ Save yourself that trip to the market — Instacart delivers groceries in as fast as 1 hour! They connect you with Personal Shoppers in your area to shop and deliver groceries from your favorite stores.Instacart - Groceries delivered in as little as 1 hour. Free delivery on your first order over $35. Hey Ketones Krew! I have a Free Keto guide on how to calculate your Macros Correctly In this guide, You will learn the importance of each of the macronutrients and how to calculate your macros to meet your weight loss goals. There's a lot of Versions of keto out there that are notthe best way of doing keto.Download: FREE GUIDE DOWNLOADSupport the show

Today, we have the pleasure of introducing our special guest, Elaina Wang, a certified nutrition coach who has an incredible story of reclaiming her health from chronic illness. Elaina's journey is nothing short of inspiring, and she has dedicated her life to advocating for and assisting others in discovering the transformative power of the Ketogenic way of life.In this episode, Elaina shares her personal transformation story, from battling chronic illness to finding a path towards optimal health. Elaina's passion for helping others shines through as she discusses her journey into coaching. On this Episode: Introduction to Elaina Wang2:24 Conquering Childhood Obesity, Chronic Illness, and Addiction4:41 Unraveling Epstein Bar Syndrome6:53 Path from Emotional Eating to Empowered Transformation19:49 Exploring the Role of Hypnosis in Addiction9:04 Confronting Early-Onset Diabetes10:50 Finding Hope in the Face of Addiction and Diabetes19:41 Choosing Sobriety: Elaina Wang's Inspiring Path to Recovery21:46 Ketogenic diet for Diabetes Control33:30 From Personal Growth to Empowering OthersShow Links:Link to Elaina Wang's bio:My website: People can contact me through my website.Call to action for listeners: Follow ketones and Coffee Podcast on Instagram ( https://www.instagram.com/keton.esncoffee ), Youtube ( https://www.youtube.com/channel/UCsZZmBEenvZnU8tA1npAODA ), and Twitter ( https://twitter.com/KetonesP ) for updates and new episodes.~~~~~~Estrella by Audiorezout is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License.~~~~~~ Save yourself that trip to the market — Instacart delivers groceries in as fast as 1 hour! They connect you with Personal Shoppers in your area to shop and deliver groceries from your favorite stores.Instacart - Groceries delivered in as little as 1 hour. Free delivery on your first order over $35. Go to ketocoachlorenz.com and use the contact form to get your Free Consultation!Support the show

In this episode we talk about how steroid injection's mess with diabetes control, faulty sensors and more! Oh and nice biscuits or if your Jack Neeece biscuits haha! Lots of giggles in this one! 

Join Dr Carol Wysham and Dr Katherine Tuttle as they discuss advances in kidney disease management in patients living with type 2 diabetes. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982416). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification https://pubmed.ncbi.nlm.nih.gov/12859163/ KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease https://pubmed.ncbi.nlm.nih.gov/32998798/ Prevalence of Non-diabetic Kidney Disease and Inability of Clinical Predictors to Differentiate It From Diabetic Kidney Disease: Results From a Prospectively Performed Renal Biopsy Study https://pubmed.ncbi.nlm.nih.gov/36517108/ Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) https://repository.niddk.nih.gov/studies/edic/ UK Prospective Diabetes Study https://www.dtu.ox.ac.uk/ukpds/ Kidney Disease and Obesity: Epidemiology, Mechanisms and Treatment https://pubmed.ncbi.nlm.nih.gov/28090083/ Diet and Chronic Kidney Disease https://pubmed.ncbi.nlm.nih.gov/31728497/ SGLT2 Inhibitors and the Diabetic Kidney https://pubmed.ncbi.nlm.nih.gov/27440829/ GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms https://pubmed.ncbi.nlm.nih.gov/32694999/ Cardiovascular Outcomes Trials: A Paradigm Shift in the Current Management of Type 2 Diabetes https://pubmed.ncbi.nlm.nih.gov/35927730/ Effects of Long-term Antihypertensive Treatment on Kidney Function in Diabetic Nephropathy https://pubmed.ncbi.nlm.nih.gov/4077229/ A Randomized Trial of Intensive Versus Standard Blood-Pressure Control https://pubmed.ncbi.nlm.nih.gov/26551272/ Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus https://pubmed.ncbi.nlm.nih.gov/20228401/ Effects of a Fixed Combination of Perindopril and Indapamide on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes Mellitus (the ADVANCE Trial): A Randomised Controlled Trial https://pubmed.ncbi.nlm.nih.gov/17765963/ Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) https://pubmed.ncbi.nlm.nih.gov/36202661/ Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes https://pubmed.ncbi.nlm.nih.gov/27299675/ Empagliflozin in Heart Failure With a Preserved Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/34449189/ Cardiovascular and Renal Outcomes With Empagliflozin in Heart Failure https://pubmed.ncbi.nlm.nih.gov/32865377/

If you'd like to see how I can help you have better control of your Diabetes Apply to work with me here Please remember to hit subscribe and leave me a rating and review if you enjoy this episode ;) Also screen shot and share it on your stories and social profiles as this really helps me reach and help more Type 1 Diabetics. You can reach out to me at ... INSTAGRAM: @type1_tom FACEBOOK: Type1Tom Email: Tom@type1tom.co.uk Download my FREE ebook: https://tafitness.activehosted.com/f/13 Join my FREE FB community: https://www.facebook.com/groups/505161143554884/?ref=share

The acceptance and growth of the Health Coach industry is credited to the influx of research. The value is clear when you provide impact evidence supporting the effectiveness of coaching intervention. But, how do you know which study or journal is a trusted resource? Listen as Dr. Sandi, FMCA Founder and CEO, provides insight into evaluating reports and why it's significant. Randomized controlled trials (RCT) are considered the gold standard because they deliver the highest level of evidence, due to their potential to limit bias and subjective influence. References 1. Effectiveness of Short-Term Health Coaching on Diabetes Control and Self-Management Efficacy: A Quasi-Experimental Trial https://www.frontiersin.org/articles/10.3389/fpubh.2019.00314/full 2. A personalized multi-interventional approach focusing on customized nutrition, progressive fitness, and lifestyle modification resulted in the reduction of HbA1c, fasting blood sugar and weight in type 2 diabetes: a retrospective study https://pubmed.ncbi.nlm.nih.gov/36419152/ 3. Effectiveness of a Health Coaching Intervention for Patient-Family Dyads to Improve Outcomes Among Adults With Diabetes: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/36374502/ Supported by data-driven, science-based research, and published studies.

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006–2020  Changes in Glucose Metabolism and Glycemic Status with Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants with Prediabetes in the STEP Program  Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline  Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes—Post Hoc Analyses From the DECLARE- TIMI 58 Trial  Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial    For more information about each of ADA's science and medical journals, please visitwww.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

ResourcesAND Scope - https://www.eatrightpro.org/practice/quality-management/scope-of-practiceJTA for Health Coaches: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924333/  NBHWC - https://nbhwc.org/  Information on the NBHWC Coaching Log: https://nbhwc.org/coaching-log/  Effectiveness of Short-Term Health Coaching on Diabetes Control and Self-Management Efficacy: A Quasi-Experimental Trial - https://doi.org/10.3389/fpubh.2019.00314Clinical Effectiveness of Lifestyle Health Coaching - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125027/Long-term effectiveness of health coaching in rehabilitation and prevention: A systematic review - https://www.sciencedirect.com/science/article/pii/S073839911730246XAMA Presse Release: https://www.24-7pressrelease.com/press-release/466893/american-medical-association-approves-new-category-iii-cpt-codes-for-coaching.  Taxonomy Information from NBHWC: https://nbhwc.org/taxonomy-code-for-health-wellness-coaches/  Taxonomy for Health Coaches: https://taxonomy.nucc.org/?searchTerm=coach  Info on Taxonomy: https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/Find-Your-Taxonomy-Code  ACSM Scope - https://www.acsm.org/blog-detail/acsm-certified-blog/2019/09/09/nutrition-scope-of-practice  Scope of Practice Decision Algorithm: https://www.eatrightpro.org/practice/quality-management/scope-of-practice  Link to AND Scope: https://www.jandonline.org/article/S2212-2672(17)31624-6/fulltext  PA Code: http://www.pacodeandbulletin.gov/Display/pacode?file=/secure/pacode/data/049/chapter21/subchapGtoc.html&d=reduce  NCP Information: https://www.eatrightpro.org/practice/quality-management/nutrition-care-process  Academy Definition of Terms - www.eatrightpro.org/scope -------------------------------------------------------------- ● https://porrazzanutrition.com ● https://www.facebook.com/MyDietitianJourney ● https://www.instagram.com/mydietitianjourney/ ● https://mydietitianjourney.wordpress.com/ -------------------------------------------------------------- Felicia Porrazza is a registered and licensed dietitian with a masters degree in dietetics administration, an ACSM certified personal trainer, National Board Certified Health & Wellness Coach, college nutrition faculty instructor, and owner of Porrazza Nutrition LLC and My Dietitian Journey. In her private practice, she works one-on-one with clients to help them develop an understanding of healthy eating and fitness. She specializes in combining plant-based eating with fitness programs, specifically targeting beginner strength-training. Felicia has been a mentor to Dietitians starting their own private practice and a dietetic internship preceptor for Dietetic students.Disclaimer: Information provided is not intended to constitute legal or medical advice. All information is for general educational purposes only.

If you'd like to see how I can help you have better control of your Diabetes Book your FREE Strategy call here "I've was doing ok then i lost momentum" this is something i hear from a lot of Type 1's when it comes to managing their glucose levels so here's 3 strategies that i personally use and get all my clients to use to help reagin momentum Please remember to hit subscribe and leave me a rating and review if you enjoy this episode ;) Also screen shot and share it on your stories and social profiles as this really helps me reach and help more Type 1 Diabetics. You can reach out to me at ... INSTAGRAM: @type1_tom FACEBOOK: Type1Tom Email: Tom@type1tom.co.uk Download my FREE ebook: https://tafitness.activehosted.com/f/13 Join my FREE FB community: https://www.facebook.com/groups/505161143554884/?ref=share

A recent case control study evaluated adverse effects on glycemic control secondary to cholesterol lowering statin medications. Listen in as we evaluate the risk versus benefit of statin therapy in persons with diabetes.  Redeem your CPE or CME credit here!Claim CPE (Pharmacist Members) Claim CMENeed a membership?Join for CPE CreditJoin for CME CreditReferences and resources: Mansi IA, Chansard M, Lingvay I, et al. Association of Statin Therapy Initiation With Diabetes Progression: A Retrospective Matched-Cohort Study. JAMA Intern Med. Published online October 04, 2021. doi:10.1001/jamainternmed.2021.5714Learning Objectives: 1. Describe the proposed mechanism by which statins would worsen blood glucose control2. Discuss confounders in the study that examined the association of statin use and worsening diabetes control.Continuing Education Information:0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-21-365-H01-PInitial release date: 11/15/21Expiration date: 11/15/22Complete CPE & CME details can be found here

Dr. Eden Miller, a diabetologist, obesity medicine specialist, and family practitioner returns to the podcast to discuss additional topics in diabetes and obesity management.

A database review published in the Journal of Hospital Medicine finds a role for sliding scale insulin monotherapy for some admitted patients with type 2 diabetes. Inpatient Glycemic Control With Sliding Scale Insulin in Noncritical Patients With Type 2 Diabetes: Who Can Slide?

¿Sabias Que ?En México hay una alta incidencia de pacientes con diabetes, hay una prevalencia 13.7 % y el 10.4% saben que tienen diabetes y no saben como cuidarla. Hoy en día México es el 6° País con mayor cantidad de pacientes con diabetes, es por ello que Ethel y La Director Medico de Sanofi México traen para ti alternativas para esta enfermedad. See acast.com/privacy for privacy and opt-out information.

A1C is an easy way to diagnose and monitor diabetes, use and limitations of A1C are discussed with Dr Rodriguez. Vaginal metformin is mentioned as an anecdote which has not been proven to work we remembered Memorial Day. Introduction: Vaginal Metformin.  By Hasaney Sin, MD, and Hector Arreaza, MD.Today is May 31, 2021.  There’s a saying that I came across on social media that has always spoken to me which I find relevant to our vocation. “The more I learn, the more I find out I don’t know”. So comes the joys (and challenges) of our chosen career. Case in point, have you ever heard of vaginal metformin? Neither have I, until today. There was a randomized clinical trial plan in 2013 at Assuit University in Egypt studying the effectiveness of vaginal metformin for the treatment of polycystic ovarian syndrome (PCOS). As primary care providers, we are very aware of the gastrointestinal side effects of metformin when taken PO. This sometimes prevents compliance with metformin. The study at Assuit University was to study the effectiveness of metformin when given vaginally in the effectiveness of treating PCOS, while also decreasing the undesirable side effects of metformin when given PO in hopes of also ultimately improving adherence. Unfortunately, the study was planned to be finished in 2014, but no results have been published thus far[1]. Stay tuned in case there is any update.Arreaza: I had to do a search because I was very curious too. There is at least one occurrence when vaginal metformin was mentioned, at least in English. It was in an online forum where a doctor recommended vaginal metformin for PCOS to a patient. This has not been evaluated or approved by any organization, so I would not recommend it. You know what would be great? Metformin patches! There you have a business idea guys: The Metfo-patch®. This is Rio Bravo qWeek, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California. Our program is affiliated with UCLA, and it’s sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. Introduction: Memorial Day. Written by Valerie Civelli, MD, read by Steven Saito, MD, and Hector Arreaza, MDWhat is Memorial Day? Memorial Day is an American holiday at the end of May to honor the men and women who died while serving in the US military. It has great historical meaning to Americans. It originated from the Civil War which claimed more lives than any other conflict in US history. Civil war ended in 1865.   A fun fact to know, is that Memorial Day, was originally called “Decoration Day”.  It was 3-years after the Civil war ended, May 5, 1868, that “Decoration Day” was declared as a time for the nation to decorate the graves of those lost in war.  Graves were adorned with flowers and their lives celebrated.  Maj. Gen. John A. Logan then declared that “Decoration Day” should be observed on May 30th. It is believed that this date was chosen because flowers would be in full bloom across the country. The “birthplace” of “Memorial Day” was recognized as coming from Waterloo, New York, because Waterloo was the first to use this term to expand honor and recognition of all US fallen soldiers of war from the Civil War and from World War I. In 1971, “Memorial Day” was officially declared a national federal holiday: The National Moment of Remembrance encourages all Americans to pause wherever they are at 3:00 p.m. local time on Memorial Day for a minute of silence, to remember and honor those who have died in service to the nation. If you value your freedom wherever you are, this Memorial Day at 3:00 p.m., pause for a minute to recognize all of our military men and women, both past and present who served and continue to serve our country. We honor every soldier who lost his or her life in any war against America. You are the reason for our freedoms.  You gave the ultimate sacrifice, and we do not take this for granted. To all military members who have died at war, we appreciate the privileges we have today because of you. We honor the costly price at which it came.  We remember you. We honor you. We sincerely thank you. Happy Memorial Day everyone! ___________________________A1C.By Hector Arreaza, MD, and Yodaisy Rodriguez, MD.   Definition. Glycated hemoglobin (glycohemoglobin, hemoglobin A1c, or just A1c) is a form of hemoglobin that is chemically linked to a sugar. Glucose spontaneously bind with hemoglobin, when present in the bloodstream of humans.A1C refers to the percentage of glycosylation of the hemoglobin A1C chain and correlates with the average blood glucose levels over the previous 2-3 months from the slow turnover of red blood cells in the body. A RBC lives 120 days.History of A1C. Huisman and Meyering separated glycohemglobin for the first time in 1958. A1c for monitoring the degree of control of glucose metabolism in diabetic patients was proposed in 1976 by Anthony Cerami, Ronald Koenig and coworkers.A1C was first included in the ADA guidelines as a diagnostic test for diabetes in 2010. Prior to that random glucose or fasting plasma glucose were used for diagnosis.For diagnosis of diabetes, A1C testing should be done by a technique certified by the National Glycohemoglobin Standardization Program and consistent with the Diabetes Control and Complications Trial reference assay.A1C levels. A1C 6.5% is diabetes.Of note, other criteria for diagnosing diabetes: Fasting plasma glucose >126 mg/dL, 2-hour plasma glucose > 200, random glucose >200 plus classic symptoms.In patients with prediabetes, A1C should be tested yearly.The American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Use ADA guidelines to assess targets.Point-of-care A1C (POC A1C): POC is not recommended for screening or diagnosis but it is good for monitoring.A1C limitations.There are some limitations to A1C testing, and an incomplete correlation between A1C level and average glucose level in certain individuals.Nonglycemic Factors That May Interfere with A1C MeasurementFalsely lower A1C: Acute blood loss, Chronic liver disease, Hemolytic anemias, Patients receiving antiretroviral treatment for human immunodeficiency virus, Pregnancy, Vitamins E and C. Patients being treated for iron, B12 or folate deficiency, EPO, chronic hemolysis (thalassemia). Lower or elevate A1C: Hemoglobinopathies or hemoglobin variants, Malnutrition Falsely elevate A1C: Aplastic anemias, Hyperbilirubinemia, Hypertriglyceridemia, Iron deficiency anemias, Renal failure, Splenectomy.For example, when RBCs have a short life, like in acute bleeding, the A1C is falsely low. On the other hand, when RBCs live longer (history of splenectomy and aplastic anemias) the A1C is falsely elevated. It’s a good idea to do CBC with A1C.Ethnic groups: Hemoglobinopathies or hemoglobin variants can change A1C levels and may be more prevalent among certain racial and ethnic groups. A1C tends to be higher in some races/ethnic groups: AA, Hispanic-Americans, Asian-Americans.Other A1C limitations: It gives you an average, patient may be experiencing hypoglycemia alternated with hyperglycemia and result in normal A1C. Screening for diabetes.ADA: Screen for diabetes or prediabetes all asymptomatic adults, according to the ADA, who have overweight or obesity with one or more risk factor (first degree relative with diabetes, high risk race or ethnic group, history of CVD, hypertension, dyslipidemia, PCOS, physical inactivity, severe obesity, acanthosis nigricans), patients with prediabetes (every year), women with GDM (every 3 years), all other patients after 45 years of age. If results are normal, test every 3 years, patients with HIV.USPSTF: Adults aged 40 to 70 years who are overweight or obese. The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. (Draft: Asymptomatic adults ages 35 to 70 years who are overweight or obese) This is a Grade B recommendation. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. The USPSTF recommends screening for gestational diabetes mellitus (GDM) in asymptomatic pregnant women after 24 weeks of gestation. This is a Grade B recommendation.Grade I recommendation (insufficient evidence): Asymptomatic pregnant women, Before 24 Weeks of Gestation. The USPSTF concludes that the current evidence is insufficient to screen for GDM in asymptomatic pregnant women before 24 weeks of gestation.A1C Targets.A1C goals can range from 6.5% to 8%. Target is individualized based on life expectancy, disease duration, presence of complications, CVD risk factors, comorbid conditions and risks for severe hypoglycemia. Sometimes your goal can be independent of A1C, for example, your goal can be to avoid complications. As a fun fact, A1C is not used in veterinary medicine.Conclusion.By Hector Arreaza, MD. Now we conclude our episode number 54 “A1C”, three characters that may not mean much for most people but for patients with diabetes, it is a very important number to remember. Remember to check the A1C in all your patients with poor control of diabetes every 3 months, or every 6 months in patients with good control. A1C has its limitations but it certainly is the best way to assess your patients’ glycemic control. We started this episode by giving you a random report about vaginal metformin, the study was unfinished, and we also reminded you of the importance of remembering our heroes during Memorial Day. Even without trying, every night you go to bed being a little wiser.Thanks for listening to Rio Bravo qWeek. If you have any feedback about this podcast, contact us by email RBresidency@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. This podcast was created with educational purposes only. Visit your primary care physician for additional medical advice. This week we thank Hector Arreaza, Hasaney Sin, Valerie Civelli, Yodaisy Rodriguez, and Steven Saito. Audio edition: Suraj Amrutia. See you next week!References:Vaginal Administration of Metformin in PCOS Patients, U.S. National Library of Medicine, Clinical Trials.Gov, https://clinicaltrials.gov/ct2/show/study/NCT02026869. Office of Public and Intergovernmental Affairs, U.S. Department of Veteran Affairs,  https://www.va.gov/opa/speceven/memday/history.asp, accessed on May 26, 2021.  Pippitt K, Li M, Gurgle HE. Diabetes Mellitus: Screening and Diagnosis. Am Fam Physician. 2016 Jan 15;93(2):103-9. Erratum in: Am Fam Physician. 2016 Oct 1;94(7):533. PMID: 26926406. https://www.aafp.org/afp/2016/0115/p103.html. Standards of Medical Care in Diabetes – 2021, Diabetes Care, January 1, 2021, vol 44 issue supplement 1, https://care.diabetesjournals.org/content/diacare/suppl/2020/12/09/44.Supplement_1.DC1/DC_44_S1_final_copyright_stamped.pdf.

While the numbers are constantly rising, more than 1 in 10 Americans – or more than 34 million people – live with diabetes already today. For many of them, nerve damage caused by diabetes – a condition called diabetic neuropathy – is a common complication that can cause painful shooting and stabbing sensations along with burning, tingling and numbness that affect the lower extremities. To understand more about the challenges patients face due to this condition, a new national survey reveals its findings on what it truly means to live with diabetic nerve pain. Here to discuss neuropathic pain associated with diabetic peripheral neuropathy – or diabetic nerve pain – and the survey findings is Dr. Rodica Pop-Busui, MD, PhD, Professor of Internal Medicine, Metabolism, Endocrinology and Diabetes and Vice Chair Clinical Research, Department of Internal Medicine at the University of Michigan, Ann Arbor and Lindsay Colbert, Executive Director of the Foundation for Peripheral Neuropathy. Rodica Pop-Busui, MD, PhD, is the Larry D. Soderquist Professor of Diabetes, a prominent diabetologist at Michigan Medicine and a recognized leader in the field of diabetes and diabetes complications. She is the Vice Chair for Clinical Research in the Department of Internal Medicine and the Associate Director of Clinical Research, Mentoring and Development of the Elizabeth Weiser Caswell Diabetes Institute at the University of Michigan. Her research interests involve chronic complications of diabetes, particularly diabetic peripheral and cardiovascular autonomic neuropathy, as well as diabetic foot complications, diabetic kidney disease and cardiovascular disease, and the design and conduct of traditional and pragmatic clinical trials for patients with diabetes. Dr. Pop-Busui has published more than 200 peer-reviewed manuscripts and book chapters, and received awards from the American Diabetes Association (ADA) and the University of Michigan. She has chaired the most recent American Diabetes Association Position Statement on Diabetic Neuropathy, and has served as Chair of the American Diabetes Association Scientific Research Review Clinical and Chair of the ADA Diabetes & Cardiovascular Disease Interest Group. She is also one of the principal investigators in the recently established NIDDK Diabetes Foot Consortium. She has led neuropathy studies in several of the most important national and international diabetes clinical trials to date including: the NHLBI-funded Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, the NIDDK funded Bypass Angioplasty Revascularization Diabetes 2 (BARI- 2D) and Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. In addition, she designed and leads several investigator-initiated studies funded by NIDDK and Pharma to unveil disease modifying agents for diabetic neuropathy and other diabetes complications. Lindsay Colbert, MA, is Executive Director of the Foundation for Peripheral Neuropathy (FPN), a public charity organization based outside of Chicago, Illinois, that is dedicated to improving the lives of patients living with peripheral neuropathy. In her tenure with the organization, Colbert has lead FPN to increase awareness of peripheral neuropathy, prioritize research and funding in the field, and provide educational programs to patients throughout the world who are desperate for answers and hope. Colbert holds a Master of Arts degree in International Development and French from the University of Wisconsin-Madison. Prior to joining FPN in 2017, Colbert developed her marketing, fundraising and nonprofit management skills for over a decade at two Chicago-based institutions, namely Rotary International and Northwestern University. She resides in a Chicago suburb with her husband and two daughters. In her free time, Colbert enjoys traveling, cycling, gardening, and playing with her children.

Having great control over your diabetes is hard and take a lot of brain power but I promise you it pays off, find out more in this episode. Please remember to hit subscribe and leave me a rating and review if you enjoy this episode ;) Also screen shot and share it on your stories and social profiles as this really helps me reach and help more Type 1 Diabetics. If you'd like to see how I can help you have better control of your Diabetes Book your FREE Strategy call here You can reach out to me at ... INSTAGRAM: @type1_tom FACEBOOK: Type1Tom Email: Tom@type1tom.co.uk Download my FREE ebook: https://tafitness.activehosted.com/f/13 Join my FREE FB community: https://www.facebook.com/groups/505161143554884/?ref=share

  contact@frcapodcast.com  

In this podcast Tracy Herbert discusses the importance of Melatonin, not just for better sleep, but for diabetes and diabetes complications. The research is shocking how improving Melatonin levels can help with diabetes, Alzheimer’s Disease, Parkinson’s Disease, improve anti-inflammatory markers, along with macular degeneration. Research is showing that increasing melatonin improves glycemic control, blood pressure, and mental health issues. Check out all the research showing the importance of this critical hormone. Melatonin and diabetes: https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-020-00537-z#:~:text=Melatonin%20has%20been%20shown%20to,glucose%20intolerance%20and%20insulin%20resistance Oxidative stress and diabetes: https://pubmed.ncbi.nlm.nih.gov/29275919/ Decreased melatonin in rats with diabetes: https://pubmed.ncbi.nlm.nih.gov/19695268/ Melatonin and longevity: https://link.springer.com/chapter/10.1007/978-3-319-63001-4_10 Regulates body temperature: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767594/ Blood Pressure: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227197/ Foods to increase melatonin: https://www.webmd.com/diet/foods-high-in-melatonin#1 Melatonin change though the seasons: https://health.clevelandclinic.org/melatonin-how-much-should-i-take-for-a-good-nights-rest/

In this podcast Tracy Herbert shares research on the importance of gum health, oral health, and its connection with living longer. Even if you fear going to the dentist, it’s critical for overall health, living longer, and blood sugar control. Visiting the dentist for teeth cleaning and regular dental exams is critical for good health. Dental Treatment Helps Lower Hemoglobin A1c: https://www.endocrineweb.com/news/diabetes/59025-dental-treatment-helps-lower-your-hemoglobin-a1c CDC and Oral Health: https://www.cdc.gov/oralhealth/conditions/index.html CDC and Cost Related to Dental Issues: https://www.cdc.gov/oralhealth/conditions/index.html Mayo Clinic Overall Health and Oral Health: https://www.mayoclinic.org/healthy-lifestyle/adult-health/in-depth/dental/art-20047475 Want to live longer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124861/

Emotional management for people with type 1 diabetes is an essential part of taking care of yourself. We're not taught this in school, even though managing our emotions is a foundational skill that affects every other part of life, including diabetes management.Find the show notes herePodcast pageLife coaching for type 1 diabeticsSupport the show (https://www.inspiredforward.com/kofi)

In this podcast Tracy Herbert shares up-to-date research on the importance of Vitamin D for better health and diabetes management. And learn the surprising results from a Boston University study showing a correlation between low Vitamin D levels and increased COVID -19 risk. Islet Cell Death Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769474/ Insulin Resistance Weight Gain Connection Dr. Al Sears: https://alsearsmd.com/2020/10/vitamin-d-deficiency-has-lead-to-weight-gain/ Insulin Resistance and Vitamin D Study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408731/ Vitamin D and Damage Healing Caused by Blood Pressure: https://pubmed.ncbi.nlm.nih.gov/29416330/ Vitamin D and Diabetes Control: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426990/#b8-0540864 Mayo Clinic Recommendations: https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-q-and-a-how-much-vitamin-d-do-i-need/#:~:text=Mayo%20Clinic%20recommends%20that%20adults,may%20have%20additional%20health%20benefits. Dr Anthony Fauci article: https://www.cnbc.com/2020/09/26/how-to-know-if-you-have-a-vitamin-d-deficiency.html?__source=androidappshare

Join Dr. Grady and Garrett, both Type 1 Diabetics, as they talk about blood sugar, overall health, and how to take control of your health to gain the freedom to live the life you deserve. In this episode, we discuss why it is important for us to maintain good blood sugar control. We talk about the immediate benefits of good blood sugar levels such as sleep, mental and physical performance, and brainpower. We also get into the long-term considerations of maintaining tight blood sugar control like circulation, eyes, and kidney health.  PLEASE SUBSCRIBE TO THE PODCAST For more Diabuddies content follow us on The Diabuddies Podcast Facebook page. Twitter: @TheDiabuddies Instagram: @thediabuddiespodcast You can email us at TheDiabuddiesPodcast@gmail.com   Resources/Links Discussed in the episode: “The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility Phase.” Diabetes, vol. 35, no. 5, 1986, pp. 530–545., doi:10.2337/diab.35.5.530. Gaete, Ximena, et al. “Menstrual Cycle Irregularities and Their Relationship with HbA1c and Insulin Dose in Adolescents with Type 1 Diabetes Mellitus.” Fertility and Sterility, vol. 94, no. 5, 2010, pp. 1822–1826., doi:10.1016/j.fertnstert.2009.08.039. Huang, Chun-Jen, et al. “Prevalence and Incidence of Diagnosed Depression Disorders in Patients with Diabetes: a National Population-Based Cohort Study.” General Hospital Psychiatry, vol. 34, no. 3, 2012, pp. 242–248., doi:10.1016/j.genhosppsych.2011.12.011. King, Paromita, et al. “The UK Prospective Diabetes Study (UKPDS): Clinical and Therapeutic Implications for Type 2 Diabetes.” British Journal of Clinical Pharmacology, vol. 48, no. 5, 2001, pp. 643–648., doi:10.1046/j.1365-2125.1999.00092.x.

  Episode 278 is an all inclusive guide to kidney anatomy, health, bloodwork, and MORE for physique and performance based athletes! First I dig into some basics on kidney anatomy and function before moving into some considerations for athletes looking to get bloodwork done to track kidney health, and all before ending with practical application on how to maintain kidney health while pushing for your goals! Also, theres a few references I'll provide below for those looking to take things further!   REFERENCES Adelstein RS, Sellers JR. Effects of calcium on vascular smooth muscle contraction. The American journal of cardiology. Jan 30 1987;59(3):4b-10b.   Agre P, King LS, Yasui M, Guggino WB, Ottersen OP, Fujiyoshi Y, . . . Nielsen S. Aquaporin water channels--from atomic structure to clinical medicine. The Journal of physiology. Jul 1 2002;542(Pt 1):3-16.   AHA. American Heart Association. Kidney Damage and High Blood Pressure. Available at: http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/WhyBloodPressureMatters/Kidney-Damage-and-High-Blood-Pressure_UCM_301825_Article.jsp. Last updated 9/11/2014a. Accessed 8/10/2014.     Akinwusi PO, Oluyombo R, Ogunro PS, Adeniji AO, Okunola OO, Ayodele OE. Low dose aspirin therapy and renal function in elderly patients. International journal of general medicine. 2013;6:19-24.   Al-Awqati Q, Barasch J, Goldman L (ed.), SchaferAI (ed.). Goldman's Cecil Medicine, Twenty-Fourth Edition. Chapter 117: Structure and Function of the Kidneys; 716-720. Copyright 2012 Saunders, an imprint of Elsevier, Inc. Available at: www.clinicalkey.com Accessed: 6/9/2014.   Alpern RJ, Sakhaee K. The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. American journal of kidney diseases : the official journal of the National Kidney Foundation. Feb 1997;29(2):291-302.   Amodu A, Abramowitz MK. Dietary acid, age, and serum bicarbonate levels among adults in the United States. Clinical journal of the American Society of Nephrology : CJASN. Dec 2013;8(12):2034-2042.   Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney international. Jun 2013;83(6):1010-1016.   Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, and Thornalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes. 2003;52(8):2110–20   Bae EH, Lee J, Ma SK, et al. alpha-Lipoic acid prevents cisplatin-induced acute kidney injury in rats. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2009;24(9):2692–700   Balakumar P, Bishnoi HK, Mahadevan N. Telmisartan in the management of diabetic nephropathy: a contemporary view. Current diabetes reviews. May 2012;8(3):183-190.   Balakumar P, Rohilla A, Krishan P, Solairaj P, and Thangathirupathi A. The multifaceted therapeutic potential of benfotiamine. Pharmacol. Res. 2010;61(6):482–8   Bankir L, Bouby N, Trinh-Trang-Tan MM, Ahloulay M, Promeneur D. Direct and indirect cost of urea excretion. Kidney international. Jun 1996;49(6):1598-1607.   Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnesium research : official organ of the International Society for the Development of Research on Magnesium. Sep 2010;23(3):131-137.   Bashir B, Sharma SG, Stein HD, Sirota RA, D'Agati VD. Acute kidney injury secondary to exposure to insecticides used for bedbug (Cimex lectularis) control. American journal of kidney diseases : the official journal of the National Kidney Foundation. Nov 2013;62(5):974-977.   Baynes JW, Dominiczak MH. Medical Biochemistry, Fourth Edition. Chapter 23: Role of Kidneys in Metabolism; 309-319. Copyright 2014, Elsevier Limited. Available at: www.clinicalkey.com. Accessed 6/9/2014.   Bellizzi V. Low-protein diet or nutritional therapy in chronic kidney disease? Blood purification. 2013;36(1):41–6   Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical care (London, England). Aug 2004;8(4):R204-212.   Bertelli AAE, Migliori M, Panichi V. Resveratrol, a component of wine and grapes, in the prevention of kidney disease. Ann N Y Acad Sci. 2002;957:230–8   Brodin EE, Braekkan SK, Vik A, Brox J, Hansen JB. Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromso study. Haematologica. Jul 2012;97(7):1008-1013.   Busch M, Franke S, Ruster C, and Wolf G. Advanced glycation end-products and the kidney. Eur J Clin Invest. 2010;40(8):742–55   Cacciapuoti F. Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. Dec 2012;23(8):677-679.   Calhoun DA. Hyperaldosteronism as a common cause of resistant hypertension. Annu. Rev. Med. 2013;64:233–47   Ceglia L, Harris SS, Abrams SA, Rasmussen HM, Dallal GE, Dawson-Hughes B. Potassium bicarbonate attenuates the urinary nitrogen excretion that accompanies an increase in dietary protein and may promote calcium absorption. The Journal of clinical endocrinology and metabolism. Feb 2009;94(2):645-653.   Chao MC, Hu SL, Hsu HS, Davidson LE, Lin CH, Li CI, . . . Lin WY. Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population. Journal of nephrology. Jan 16 2014.   Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: a review. Biological trace element research. May 2010;134(2):119-129.   Chen J, Muntner P, Hamm LL, et al. The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults. Ann Intern Med. 2004;140(3):167–74   Chen Y, Abbate M, Tang L. L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 2014;99(2):408–22   Cheungpasitporn W, Thongprayoon C, OA OC, Edmonds PJ, Kittanamongkolchai W, Erickson SB. Associations of Sugar and Artificially Sweetened Soda and Chronic Kidney Disease: A Systematic Review and Meta-analysis. Nephrology (Carlton, Vic.). Sep 23 2014.   Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Zeimbekis A, Kastorini CM, Stefanadis C. Adherence to the Mediterranean diet is associated with renal function among healthy adults: the ATTICA study. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. May 2010;20(3):176-184.   Cohen D, Goldberg M, Gulati A, and Ferri FF. First Consult. Chronic kidney disease. Available at: www.clinicalkey.com. Last updated 5/5/2010. Accessed 6/12/2014. 2010; Available at: [Accessed August 3, 2014].   Cravedi P, Remuzzi G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol. 2013;76(4):516–23   Cunningham J, Rodríguez M, Messa P. Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients. Clinical Kidney Journal. 2012;5(Suppl 1):i39-i51.   Curiel RV, Katz JD. Mitigating the cardiovascular and renal effects of NSAIDs. Pain Med. 2013;14 Suppl 1:S23–8   Das J, Roy A, Sil PC. Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review. Food Funct. 2012;3(12):1251–64     Davis KE, Prasad C, Vijayagopal P, Juma S, Imrhan V. Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases:Links in a Chain? Critical reviews in food science and nutrition. Sep 26 2014.   De la Fuente M, Hernanz A, Viniegra S, Miquel J. Sulfur-containing antioxidants increase in vitro several functions of lymphocytes from mice. International immunopharmacology. Jun 2011;11(6):661-669.   Debreceni B, Debreceni L. The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease. Cardiovascular therapeutics. Jun 2014;32(3):130-138.   Dempsher J. The nerve impulse in the axon--a new theory. Acta biotheoretica. 1981;30(2):121-137.   Di Vito R, Sirolli V, Amoroso L, Bonomini M. [Nephrotoxicity induced by chemotherapy]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. May-Jun 2011;28(3):296-304.   Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes care. Sep 2011;34(9):2116-2122.   Downie WW. Prostaglandins and NSAID in the kidney. The Journal of rheumatology. Supplement. Mar 1991;28:19-21.   Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A. Normal and pathologic concentrations of uremic toxins. Journal of the American Society of Nephrology : JASN. Jul 2012;23(7):1258-1270.   Eknoyan G. Obesity and chronic kidney disease. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2011;31(4):397-403.   Eknoyan G, Latos DL, Lindberg J, National Kidney Foundation Carnitine Consensus Conference. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference. Am J Kidney Dis. 2003;41(4):868–76.     Faloon W. FDA Approves Deadly Drugs, Delays Lifesaving Therapies. Life Extension Magazine. http://www.lef.org//Magazine/2004/5/awsi/Page-01. May 2004. Accessed 1/26/2015.   Feng B, Yan X-F, Xue J-L, Xu L, and Wang H. The Protective Effects of α-Lipoic Acid on Kidneys in Type 2 Diabetic Goto-Kakisaki Rats via Reducing Oxidative Stress. Int J Mol Sci. 2013;14(4):6746–56   Fenton TR, Tough SC, Lyon AW, Eliasziw M, Hanley DA. Causal assessment of dietary acid load and bone disease: a systematic review & meta-analysis applying Hill's epidemiologic criteria for causality. Nutrition journal. 2011;10:41.   Ferri FF. Ferri's Clinical Advisor. Chronic Kidney Disease. Available at: www.clinicalkey.com. Copyright © 2014c. Accessed 6/12/2014.   Ferri FF. Ferri's Clinical Advisor. Acute Kidney Injury. Available at: www.clinicalkey.com. Copyright © 2014a. Accessed 6/12/2014.   Ferri FF. Ferri's Clinical Advisor. Polycystic Kidney Disease. Available at: www.clinicalkey.com. Copyright © 2014b. Accessed 6/12/2014.   Finkielstein VA, Goldfarb DS. Strategies for preventing calcium oxalate stones. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. May 9 2006;174(10):1407-1409.   Fjellstedt E, Denneberg T, Jeppsson JO, Tiselius HG. A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria. Urological research. Oct 2001;29(5):295-302.   Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. American journal of kidney diseases : the official journal of the National Kidney Foundation. Jan 2001;37(1):79-83.   Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. Journal of the American Society of Nephrology : JASN. Aug 2003;14(8 Suppl 3):S254-258.     Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Archives of internal medicine. Apr 14 2008;168(7):713-720.   Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H. Cisplatin nephrotoxicity and protection by silibinin. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. Jan 1996;11(1):55-62.   Gazdíková K, Gvozdjáková A, Kucharská J, Spustová V, Braunová Z, and Dzúrik R. Oxidative stress and plasma concentrations of coenzyme Q10, alpha-tocopherol, and beta-carotene in patients with a mild to moderate decrease of kidney function. Nephron. 2001;88(3):285   Geleijnse JM, Giltay EJ, Grobbee DE, Donders ART, and Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 2002;20(8):1493–9   Genazzani AR, Mannella P, Simoncini T. Drospirenone and its antialdosterone properties. Climacteric : the journal of the International Menopause Society. Feb 2007;10 Suppl 1:11-18.   GHR. Genetics Home Reference. Conditions page. Renal tubular dysgenesis. Available at: http://ghr.nlm.nih.gov/condition/renal-tubular-dysgenesis. 1/5/2015. Accessed 1/6/2015. 2015.     Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney international. Jan 2012;81(1):86-93.   Goraya N, Wesson DE. Dietary management of chronic kidney disease: protein restriction and beyond. Current opinion in nephrology and hypertension. Nov 2012;21(6):635-640.   Goraya N, Wesson DE. Does correction of metabolic acidosis slow chronic kidney disease progression? Current opinion in nephrology and hypertension. Mar 2013;22(2):193-197.   Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AA, Vernekar SN. Markers of renal function tests. North American journal of medical sciences. Apr 2010;2(4):170-173.   Guarnieri G, Zanetti M, Vinci P, Cattin MR, Pirulli A, Barazzoni R. Metabolic syndrome and chronic kidney disease. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. Sep 2010;20(5 Suppl):S19-23.   Gupta A, Biyani M, and Khaira A. Vancomycin nephrotoxicity: myths and facts. Neth J Med. 2011;69(9):379–83   Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE. Obesity, hypertension, and chronic kidney disease. International journal of nephrology and renovascular disease. 2014;7:75-88.   Hamilton KL, Butt AG. The molecular basis of renal tubular transport disorders. Comparative biochemistry and physiology. Part A, Molecular & integrative physiology. Jul 2000;126(3):305-321.   Hamm LL, Simon EE. Roles and mechanisms of urinary buffer excretion. The American journal of physiology. Oct 1987;253(4 Pt 2):F595-605.   Hanly L, Rieder MJ, Huang SH, Vasylyeva TL, Shah RK, Regueira O, Koren G. N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide. Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique. 2013;20(2):e132-145.   Harisa GI. Benfotiamine enhances antioxidant defenses and protects against cisplatin-induced DNA damage in nephrotoxic rats. J. Biochem. Mol. Toxicol. 2013;27(8):398–405   Hartweg J, Farmer AJ, Holman RR, and Neil HAW. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia. 2007;50(2):250–8   Hataya Y, Igarashi S, Yamashita T, and Komatsu Y. Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients. Clinical and experimental nephrology. 2013;17(4):525–31   Hawley MA. The Kidney Transplant/Dialysis Association Patient Handbook. Chapter 1: Normal and Abnormal Kidney Function. Available at: http://msl1.mit.edu/ESD10/kidneys/HndbkHTML/ch1.htm. Accessed 1/6/2015. 2015.   Hazard PB, Griffin JP. Calculation of sodium bicarbonate requirement in metabolic acidosis. The American journal of the medical sciences. Jan-Feb 1982;283(1):18-22.   Heidet L, Gubler M-C. The renal lesions of Alport syndrome. J. Am. Soc. Nephrol. 2009;20(6):1210–5   Ho MJ, Bellusci A, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev. 2009;(4):CD007435   Hodgson JM, Watts GF, Playford DA, Burke V, and Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002;56(11):1137–42   Hojs R, Bevc S, Antolinc B, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in the elderly. International journal of clinical pharmacology research. 2004;24(2-3):49-54.   Holthoff JH, Wang Z, Seely KA, Gokden N, and Mayeux PR. Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney Int. 2012;81(4):370–8   Houston M. The role of magnesium in hypertension and cardiovascular disease. Journal of clinical hypertension (Greenwich, Conn.). Nov 2011;13(11):843-847.   Kanda E, Ai M, Yoshida M, Kuriyama R, Shiigai T. High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients. BMC nephrology. 2013;14:4.   Karachalias N, Babaei-Jadidi R, Rabbani N, and Thornalley PJ. Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes. Diabetologia. 2010;53(7):1506–16   Karalius VP, Shoham DA. Dietary sugar and artificial sweetener intake and chronic kidney disease: a review. Advances in chronic kidney disease. 2013;20(2):157–64   Karimi G, Ramezani M, Tahoonian Z. Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evidence-based complementary and alternative medicine : eCAM. Sep 2005;2(3):383-386.   Karsai T, Elodi P. Urea cycle enzymes in human liver: ontogenesis and interaction with the synthesis of pyrimidines and polyamines. Molecular and cellular biochemistry. 1982;43(2):105-110.   Kaur J. A comprehensive review on metabolic syndrome. Cardiology research and practice. 2014;2014:943162.   Kaysen GA. Albumin turnover in renal disease. Mineral and electrolyte metabolism. 1998;24(1):55-63.   Khalifeh N, Haider D, Horl WH. Natriuretic peptides in chronic kidney disease and during renal replacement therapy: an update. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. Jan 2009;57(1):33-39.   Khan SA, Priyamvada S, Khan W, Khan S, Farooq N, and Yusufi ANK. Studies on the protective effect of green tea against cisplatin induced nephrotoxicity. Pharmacol. Res. 2009;60(5):382–91   Kihm LP, Müller-Krebs S, Klein J. Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis. J. Am. Soc. Nephrol. 2011;22(5):914–26   Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Journal of the American Society of Nephrology : JASN. Jul 2005;16(7):2134-2140.   Kurtz TW. Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator. Acta diabetologica. Apr 2005;42 Suppl 1:S9-16.   LaCivita C, Funkhouser E, Miller MJ, Ray MN, Saag KG, Kiefe CI, . . . Allison JJ. Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007. Journal of the American Pharmacists Association : JAPhA. Sep-Oct 2009;49(5):e110-117.   Lacour B, Parry C, Drüeke T, et al. Pyridoxal 5'-phosphate deficiency in uremic undialyzed, hemodialyzed, and non-uremic kidney transplant patients. Clin. Chim. Acta. 1983;127(2):205–15   Lahoti TS, Patel D, Thekkemadom V, Beckett R, Ray SD. Doxorubicin-induced in vivo nephrotoxicity involves oxidative stress-mediated multiple pro- and anti-apoptotic signaling pathways. Current neurovascular research. Nov 2012;9(4):282-295.   Lameire N, Kruse V, Rottey S. Nephrotoxicity of anticancer drugs--an underestimated problem? Acta clinica Belgica. 2011;66(5):337–45   Lassus J, Harjola VP. Cystatin C: a step forward in assessing kidney function and cardiovascular risk. Heart Fail Rev. 2012;17(2):251–61   Latchoumycandane C, Nagy LE, McIntyre TM. Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation. Free radical biology & medicine. Apr 2014;69:403-416.   Launay-Vacher V, Rey JB, Isnard-Bagins C, et al. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol. 2008;61(6):903-9.   Laville M, Nazare JA. Diabetes, insulin resistance and sugars. Obesity reviews : an official journal of the International Association for the Study of Obesity. Mar 2009;10 Suppl 1:24-33.   Le Vaillant J, Pellerin L, Brouard J, Eckart P. [Acetaminophen (paracetamol) causing renal failure: report on 3 pediatric cases]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. Jun 2013;20(6):650-653.   Lee JT, Peng GS, Chen SY, Hsu CH, Lin CC, Cheng CA, . . . Lin JC. Homocysteine induces cerebral endothelial cell death by activating the acid sphingomyelinase ceramide pathway. Progress in neuro-psychopharmacology & biological psychiatry. Aug 1 2013;45:21-27.   Leslie RD, Cohen RM. Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications. Journal of diabetes science and technology. Jul 2009;3(4):635-643.   Leu J-G, Lin C-Y, Jian J-H, Shih C-Y, and Liang Y-J. Epigallocatechin-3-gallate combined with alpha lipoic acid attenuates high glucose-induced receptor for advanced glycation end products (RAGE) expression in human embryonic kidney cells. An. Acad. Bras. Cienc. 2013;85(2):745–52   Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine. Mar 16 1999;130(6):461-470.   Li H, Weatherford ET, Davis DR, Keen HL, Grobe JL, Daugherty A, . . . Sigmund CD. Renal proximal tubule angiotensin AT1A receptors regulate blood pressure. American journal of physiology. Regulatory, integrative and comparative physiology. Oct 2011;301(4):R1067-1077.   Li G, Gao L, Jia J, Gong X, Zang B, and Chen W. α-Lipoic acid prolongs survival and attenuates acute kidney injury in a rat model of sepsis. Clin. Exp. Pharmacol. Physiol. 2014;41(7):459–68   Lin J, Fung TT, Hu FB, Curhan GC. Association of dietary patterns with albuminuria and kidney function decline in older white women: a subgroup analysis from the Nurses' Health Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. Feb 2011;57(2):245-254.   Lin J, Judd S, Le A, et al. Associations of dietary fat with albuminuria and kidney dysfunction. American Journal of Clinical Nutrition. 2010;92(4):897–904   Linden E, Cai W, He JC, Xue C, Li Z, Winston J, . . . Uribarri J. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clinical journal of the American Society of Nephrology : CJASN. May 2008;3(3):691-698.   Liu H, Peng Y, Li J, Liu Y, Cheng M, Yuan F, Liu F. [Stages of 3,547 patients with chronic kidney disease and relevant factor analysis]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. May 2010;35(5):499-510.   Lyman JL. Blood urea nitrogen and creatinine. Emergency medicine clinics of North America. May 1986;4(2):223-233.   Machado V, Cabral A, Monteiro P, et al. Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin). Rev Port Cardiol. 2008;27(10):1277-96.   Magill SB. Pathophysiology, diagnosis, and treatment of mineralocorticoid disorders. Comprehensive Physiology. Jul 2014;4(3):1083-1119.   Malarkodi KP, Balachandar AV, Sivaprasad R, and Varalakshmi P. Prophylactic effect of lipoic acid against adriamycin-induced peroxidative damages in rat kidney. Ren Fail. 2003;25(3):367–77   Mandayam S, Mitch WE. Dietary protein restriction benefits patients with chronic kidney disease. Nephrology (Carlton, Vic.). Feb 2006;11(1):53-57.   Mariani LH, White MT, Shults J, et al. Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2014;24(3):186–93   Marnett LJ, Rowlinson SW, Goodwin DC, Kalgutkar AS, Lanzo CA. Arachidonic Acid Oxygenation by COX-1 and COX-2: MECHANISMS OF CATALYSIS AND INHIBITION. Journal of Biological Chemistry. August 13, 1999 1999;274(33):22903-22906.   Marre M, Garcia Puig J, Kokot F, Fernandez M, Jermendy G, Opie L, . . . Asmar R. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial. Journal of hypertension. Supplement : official journal of the International Society of Hypertension. Mar 2003;21(1):S19-24.   McCarron DA. Dietary sodium and cardiovascular and renal disease risk factors: dark horse or phantom entry? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. Jul 2008;23(7):2133-2137.   MedicineNet. Metabolic Syndrome: How is metabolic syndrome defined? Available at: http://www.medicinenet.com/metabolic_syndrome/article.htm#how_is_metabolic_syndrome_defined. 9/19/2014. Accessed 9/19/2014.   Mehdi U, Toto RD. Anemia, diabetes, and chronic kidney disease. Diabetes care. Jul 2009;32(7):1320-1326.   Mekki K, Bouzidi-bekada N, Kaddous A, Bouchenak M. Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients. Food & function. Oct 2010;1(1):110-115.   Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, . . . Sarnak MJ. Cystatin C as a risk factor for outcomes in chronic kidney disease. Annals of internal medicine. Jul 3 2007;147(1):19-27.   Meola M, Petrucci I. [Ultrasound and color Doppler in nephrology. Acute kidney injury]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. Sep-Oct 2012;29(5):599-615.   Meyer BR. Renal function in aging. Journal of the American Geriatrics Society. Aug 1989;37(8):791-800.   Michael A, Faga T, Pisani A, and Riccio E. Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media. 2014;2014:249810   Minich DM, Bland JS. Acid-alkaline balance: role in chronic disease and detoxification. Alternative therapies in health and medicine. Jul-Aug 2007;13(4):62-65.   Mirmiran P, Shab-Bidar S, Hosseini-Esfahani F, Asghari G, Hosseinpour-Niazi S, Azizi F. Magnesium intake and prevalence of metabolic syndrome in adults: Tehran Lipid and Glucose Study. Public health nutrition. Apr 2012;15(4):693-701.   Mithieux G, Andreelli F, Magnan C. Intestinal gluconeogenesis: key signal of central control of energy and glucose homeostasis. Current opinion in clinical nutrition and metabolic care. Jul 2009;12(4):419-423.   Mithieux G, Misery P, Magnan C, Pillot B, Gautier-Stein A, Bernard C, . . . Zitoun C. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab. Nov 2005;2(5):321-329.   Mithieux G. A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. Nutrition (Burbank, Los Angeles County, Calif.). Sep 2009;25(9):881-884.   Moe SM, Saifullah A, LaClair RE, Usman SA, Yu Z. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN. Feb 2010;5(2):299-306.   Molnar MZ, Kalantar-Zadeh K, Lott EH, Lu JL, Malakauskas SM, Ma JZ, . . . Kovesdy CP. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. Journal of the American College of Cardiology. Feb 25 2014;63(7):650-658.   Montemurno E, Cosola C, Dalfino G, Daidone G, De Angelis M, Gobbetti M, Gesualdo L. What Would You Like to Eat, Mr CKD Microbiota? A Mediterranean Diet, please! Kidney & blood pressure research. Jul 29 2014;39(2-3):114-123.   Mori TA, Burke V, Puddey I, et al. The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial. J. Hypertens. 2009;27(9):1863–72   Mountokalakis TD. Magnesium metabolism in chronic renal failure. Magnesium research : official organ of the International Society for the Development of Research on Magnesium. Jun 1990;3(2):121-127.   Munekage E, Takezaki Y, Hanazaki K. [Shortage and metabolic disturbance of magnesium in diabetic patients and significance of magnesium replacement therapy]. Clinical calcium. Aug 2012;22(8):1235-1242.   Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annual review of pharmacology and toxicology. 1993;33:435-465.   Mussap M, Dalla Vestra M, Fioretto P, Saller A, Varagnolo M, Nosadini R, Plebani M. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney international. Apr 2002;61(4):1453-1461.   Nakamura T, Fujiwara N, Kawagoe Y, Sugaya T, Ueda Y, Koide H. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease. European journal of clinical investigation. Sep 2010;40(9):790-796.   Nakamura S, Li H, Adijiang A, Pischetsrieder M, and Niwa T. Pyridoxal phosphate prevents progression of diabetic nephropathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2007;22(8):2165–74   Nashar K, Egan BM. Relationship between chronic kidney disease and metabolic syndrome: current perspectives. Diabetes, metabolic syndrome and obesity : targets and therapy. 2014;7:421-435.   Navar LG. The kidney in blood pressure regulation and development of hypertension. The Medical clinics of North America. Sep 1997;81(5):1165-1198.   Nderitu P, Doos L, Jones PW, Davies SJ, Kadam UT. Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review. Family practice. Jun 2013;30(3):247-255.   Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney international. Jan 1995;47(1):312-318.   NHGRI. National Human Genome Research Institute. Health page. Learning About Autosomal Dominant Polycystic Kidney Disease. Last updated 4/18/2013. Accessed 1/6/2015.   NIH. National Institutes of Health. MedlinePlus. Kidney Disease: Early Detection and Treatment. Available at: http://www.nlm.nih.gov/medlineplus/magazine/issues/winter08/articles/winter08pg9-10.html. Copyright 2008. Accessed 9/19/2014.   NKDEP. National Kidney Disease Education Program. Laboratory Evaluation page. Reporting GFR. Available at: http://nkdep.nih.gov/lab-evaluation/gfr/reporting.shtml. Last updated 6/6/2012. Accessed 10/21/2014.   NKF. National Kidney Foundation. About Chronic Kidney Disease. Available at: http://www.kidney.org/kidneydisease/aboutckd. Copyright 2013a. Accessed 9/19/2014.   NKF. National Kidney Foundation. Acute Kidney Injury. Available at: http://www.kidney.org/news/kidneyCare/fall10/AcuteKidneyInjury. Copyright 2013b. Accessed 9/19/2014.   NKF. National Kidney Foundation. Statement on the release of ibuprofen as an over-the-counter medicine. Ad Hoc Committee for the National Kidney Foundation. American journal of kidney diseases : the official journal of the National Kidney Foundation. Jul 1985;6(1):4-6.     Patrick L. Mercury toxicity and antioxidants: Part 1: role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity. Altern Med Rev. 2002;7(6):456–71   Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, . . . Pugliese G. HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes care. Aug 2013;36(8):2301-2310.   Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. The New England journal of medicine. Dec 22 1994;331(25):1675-1679.   Post-White J, Ladas EJ, Kelly KM. Advances in the use of milk thistle (Silybum marianum). Integrative cancer therapies. Jun 2007;6(2):104-109.   Pozzi C, Marai P, Ponti R, Dell'Oro C, Sala C, Zedda S, Locatelli F. Toxicity in man due to stain removers containing 1,2-dichloropropane. British journal of industrial medicine. Nov 1985;42(11):770-772.   Prieto J, Qian C, Garcia N, Diez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology. Aug 1993;105(2):572-578.   PubMed Health. DASH Eating Plan. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0063068/. Last updated 6/11/2014. Accessed 10/21/2014.   Pushpakumar SB, Kundu S, Sen U. Endothelial dysfunction: The link between homocysteine and hydrogen sulfide. Current medicinal chemistry. Jul 6 2014.   Qin J, Wang H, Rets A, Harari S, Alexis H, Eid I, Pincus MR. Stability of BUN and creatinine determinations on the Siemens Advia 1800 analyzer. Journal of clinical laboratory analysis. Nov 2013;27(6):435-437.   Quigley R. Chronic kidney disease: highlights for the general pediatrician. International journal of pediatrics. 2012;2012:943904.   Radbill B, Murphy B, LeRoith D. Rationale and strategies for early detection and management of diabetic kidney disease. Mayo Clinic proceedings. Dec 2008;83(12):1373-1381.     Sabolić I. Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol. 2006;104(3):p107–14   Saddadi F, Alatab S, Pasha F, Ganji MR, Soleimanian T. The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. Jan 2014;25(1):66-72.   Sahin K, Tuzcu M, Gencoglu H, et al. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 2010;87(7-8):240–5   Saifan C, Samarneh M, Shtaynberg N, Nasr R, El-Charabaty E, and El-Sayegh S. Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements. Int J Nephrol Renovasc Dis. 2013;6:89–93   Saldanha JF, Leal Vde O, Stenvinkel P, Carraro-Eduardo JC, and Mafra D. Resveratrol: why is it a promising therapy for chronic kidney disease patients? Oxid Med Cell Longev. 2013;2013:963217   Salerno MP, Piselli P, Rossi E, Favi E, Gargiulo A, Spagnoletti G, . . . Citterio F. Metabolic syndrome and cardiovascular disease in kidney transplantation. Transplantation proceedings. May 2011;43(4):1067-1068.   Salgado JV, Souza FL, Salgado BJ. How to understand the association between cystatin C levels and cardiovascular disease: Imbalance, counterbalance, or consequence? Journal of cardiology. Dec 2013;62(6):331-335.   Samuni Y, Goldstein S, Dean OM, and Berk M. The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta. 2013;1830(8):4117–29   Scialla JJ, Appel LJ, Astor BC, Miller ER, 3rd, Beddhu S, Woodward M, . . . Anderson CA. Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN. Jul 2011;6(7):1526-1532.   Segal R, Lubart E, Leibovitz A, Iaina A, Caspi D. Renal effects of low dose aspirin in elderly patients. The Israel Medical Association journal : IMAJ. Oct 2006;8(10):679-682.   Seifter JL. Acid-base disorders. Chapter 120. Pages 741-753. In: Goldman’s Cecil Medicine. Published 12/31/2011. Available at: www.clinicalkey.com. Accessed 10/21/2014.   Sener G, Sehirli O, Ipci Y, Cetinel S, Cikler E, Gedik N, Alican I. Protective effects of taurine against nicotine-induced oxidative damage of rat urinary bladder and kidney. Pharmacology. Apr 2005;74(1):37-44.   Senturk H, Kabay S, Bayramoglu G, et al. Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney. World J Urol. 2008;26(4):401–7   Shepler B, Nash C, Smith C, Dimarco A, Petty J, and Szewciw S. Update on potential drugs for the treatment of diabetic kidney disease. Clin Ther. 2012;34(6):1237–46   Shin BC, Kwon YE, Chung JH, and Kim HL. The antiproteinuric effects of green tea extract on acute cyclosporine-induced nephrotoxicity in rats. Transplant. Proc. 2012;44(4):1080–2   Shin DH, Lee MJ, Kim SJ, et al. Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 2012;97(8):2732–40   Shishehbor MH, Oliveira LP, Lauer MS, Sprecher DL, Wolski K, Cho L, . . . Hazen SL. Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. The American journal of cardiology. Jun 15 2008;101(12):1741-1746.   Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, . . . Gansevoort RT. Cystatin C versus creatinine in determining risk based on kidney function. The New England journal of medicine. Sep 5 2013;369(10):932-943.   Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice. American journal of kidney diseases : the official journal of the National Kidney Foundation. Sep 2013;62(3):595-603.   Soto C, Pérez J, García V, Uría E, Vadillo M, and Raya L. Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus. Phytomedicine. 2010;17(14):1090–4   Soulage CO, Koppe L, Fouque D. Protein-bound uremic toxins...new targets to prevent insulin resistance and dysmetabolism in patients with chronic kidney disease. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. Nov 2013;23(6):464-466.   Stanton RC. Clinical challenges in diagnosis and management of diabetic kidney disease. American journal of kidney diseases : the official journal of the National Kidney Foundation. Feb 2014;63(2 Suppl 2):S3-21.   Starke A, Corsenca A, Kohler T, Knubben J, Kraenzlin M, Uebelhart D, . . . Ambuhl PM. Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality. Clinical journal of the American Society of Nephrology : CJASN. Sep 2012;7(9):1461-1472.   Szczepańska-Konkel M, Dominiczak MH, JW B. Medical Biochemistry, Fourth Edition. Chapter 23: Role of Kidneys in Metabolism; 309-319. Copyright 2014, Elsevier Limited. Available at: www.clinicalkey.com Accessed 6/9/2014.   Tang PC, Ng YF, Ho S, Gyda M, Chan SW. Resveratrol and cardiovascular health - Promising therapeutic or hopeless illusion? Pharmacological research : the official journal of the Italian Pharmacological Society. Dec 2014;90c:88-115.   Tanner GA, Tanner JA. Citrate therapy for polycystic kidney disease in rats. Kidney international. Nov 2000;58(5):1859-1869.   Wackenfors A, Pantev E, Emilson M, Edvinsson L, Malmsjo M. Angiotensin II receptor mRNA expression and vasoconstriction in human coronary arteries: effects of heart failure and age. Basic & clinical pharmacology & toxicology. Dec 2004;95(6):266-272.   Wagner E. Life Extension Magazine; In The News. Cystatin C Valuable in Detecting Kidney Dysfunction. http://www.lef.org//Magazine/2006/12/itn/Page-01. 2006. Accessed 1/27/2015.   Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study. Diabetes/metabolism research and reviews. Jan 2010;26(1):26-32.   Yadla M, Yanala SR, Parvithina S, Chennu KK, Annapindi N, Vishnubhotla S. Acute kidney injury in endosulfan poisoning. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. May 2013;24(3):592-593.   Yamagishi S, Nakamura K, Matsui T. Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders. Current molecular medicine. Aug 2007;7(5):463-469.   Yao X, Panichpisal K, Kurtzman N, et al. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334(2):115-24.   Yokozawa T, Nakagawa T, Oya T, Okubo T, and Juneja LR. Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy. J. Pharm. Pharmacol. 2005;57(6):773–80   Younes N, Cleary PA, Steffes MW, de Boer IH, Molitch ME, Rutledge BN, . . . Dahms W. Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Clinical journal of the American Society of Nephrology : CJASN. Jul 2010;5(7):1235-1242.   Yuzbashian E, Asghari G, Mirmiran P, Hosseini FS, Azizi F. Associations of dietary macronutrients with glomerular filtration rate and kidney dysfunction: Tehran lipid and glucose study. Journal of nephrology. Jun 5 2014.   Zheng Z, Shi H, Jia J, Li D, Lin S. Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies. BMC nephrology. 2013;14:199.   Zhu JR, Bai J, Cai NS, Tang B, Fan WH, Guo JZ, . . . Cheng NN. Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study. International journal of clinical practice. Supplement. Dec 2004(145):46-49.   Zoccali C, Curatola G, Panuccio V, Tripepi R, Pizzini P, Versace M, . . . Mallamaci F. Paricalcitol and endothelial function in chronic kidney disease trial. Hypertension. Nov 2014;64(5):1005-1011.        •••SUPPORT OUR SPONSORS•••   (COACHING) Alex - www.theprepcoach.com   (FREE OPEN FORUM w/ EXCLUSIVE VIDEOS) http://www.theprepcoachforum.com   (SUPPLEMENTS) www.projectad.me___use discount code “BFR25” to save off your order!   (RESEARCH CHEMS) www.maresearchchems.net___use discount code “alex15” to save off your order!   (SPECIALTY SUPPS) www.masupps.com___use discount code “alex20” to save off your order!   (INJECTABLE L-CARNITINE) www.synthetek.com___use discount code “alexkikel” to save off your order!   (BULK SUPPLEMENTS) www.truenutrition.com___use discount code “AXK5” to save off your order!       •••FIND THE EPISODES•••   ITUNES:https://itunes.apple.com/us/podcast/beastfitness-radios-podcast/id1065532968   LIBSYN:http://beastfitnessradio.libsyn.com   VIMEO: www.vimeo.com/theprepcoach        •••PREP COACH APPAREL•••   https://teespring.com/stores/the-prep-coach-apparel    

Expanding on Part 1 of the conversation, Craig and Laura ask James if he thinks low A1c is bad or if A1c is even the only number we should be looking at. Things that get mentioned: Blood Sugar & Other Hormones An Update on SGLT2 Inhibitors for the Treatment of Diabetes Mellitus Hypoglycemia: The neglected complication The Diabetes Control and Complications Trial (DCCT) Epidemiology of Diabetes Interventions and Complications (EDIC) Out of Range After Dark used to be an exclusive show for our Fan Club members, but we’ve made it available to everyone and added it to Out of Range. Now by joining the Fan Club, you’ll get early access to all of our posts and podcasts, input on what we talk about next, bonus clips and outtakes, a behind-the-scenes look at the making of the show, and monthly live video hangouts with the podcast creators and other Fan Club members. Unlike type 1 diabetes nonprofits, influencers, and other podcasts, Beta Cell is not funded by pharmaceutical companies, device manufacturers, or sponsored posts. We are able to keep our objectivity by relying on real people, like you, to help cover our costs. Help support our independent journalism and storytelling by joining the Fan Club.

In this podcast Tracy Herbert shares how muscle strength improves blood sugar control, lowers the risk of developing certain cancers, reduces resting blood pressure, and the list goes on. Some of our everyday activities burn more calories than you might realize. These following scientific articles are mind boggling: Study on High Intensity Interval Training and blood glucose for Type 2 diabetes: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334091/ HIIT and Type 2: https://www.sciencedaily.com/releases/2017/04/170407103559.htm WebMD article on exercise and Type 1: https://www.webmd.com/diabetes/news/19991118/diabetics-high-blood-sugar-exercise#1 Harvard Health on improving fitness levels after 70: https://www.health.harvard.edu/staying-healthy/exercise_after_age_70

In this episode, Jake Kushner, pediatric endocrinologist specializing in helping people with type 1 diabetes, discusses the best strategies to live and thrive with T1D, especially as it relates to diet and exercise. We also discuss why many patients who control their blood sugar with high amounts of exogenous insulin are at a substantially higher risk than people who can control their blood sugar at lower levels of insulin. This concept has great implications for non-diabetics as well considering the increasing prevalence of diseases related to insulin resistance. We also cover some of the basics, the history, the increasing prevalence of type 1 diabetes, and more importantly, what we can do to help kids with this disease, and their families.   We discuss: How Jake became interested in type 1 diabetes [5:30]; The pathophysiology of type 1 diabetes, the increase in prevalence, and the role of beta cells [17:00]; The role of body weight and BMI in the risk of developing T1D [27:00]; Genetics of T1D and the risk of inheritance [32:00]; Hemoglobin A1c [36:15]; Insulin: the amazing story of its discovery, its effect on cellular metabolism and IGF-1, and why the hell it’s so expensive [39:15]; Diabetes Control and Complication Trial: blood glucose and the complications associated with diabetes [54:45]; Cognitive impairment, epigenetic changes, and other dangers associated with high, peak blood glucose, and big swings in blood glucose levels [1:09:15]; Depression, anxiety, and other challenges of living with T1D [1:15:30]; Jake’s realization that the current standard of care of T1D is inadequate [1:26:15]; Managing diabetes with exercise [1:30:15]; The Bernstein method, and protein’s impact on glucose and insulin [1:36:15]; Jake radically changes his approach to treating patients [1:45:00]; What other tools are there for controlling T1D? [1:49:45]; Is the ketogenic diet appropriate for those with T1D? [1:52:45]; The most important lessons that can be applied by the non-diabetic population [1:59:00]; The two dream measurements Peter wishes were available [2:04:00]; and More. Learn more at www.PeterAttiaMD.com Connect with Peter on Facebook | Twitter | Instagram.

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes Care. 2017 Dec;40(12):1756-1762

Hi all,Welcome to the show.  It’s was my pleasure to talk with Emma O’Toole for this episode.Emma runs her own successful Yoga studio/business in Dublin, cunningly titled Yoga with Emma (www.yogawithemma.ie), and I was introduced to her through Samantha Kelly, who I interviewed near the end of Season 1. During my conversation with Samantha, the subject of Type 1 Diabetes came up as Samantha’s daughter has the condition. As I also am a Type1 Diabetic, I was interested to focus more on it in a future episode. Thanks to Samantha, Emma and I were able to make it happen.Why did I want to share this story?Since my own diagnosis, I have been learning so much about it over the last 5 years. In general, I feel it’s not a well understood condition and also can be a stigma attached to it. Education around it and the signs that it might be developing can help with an early diagnosis. Also, making others aware that someone has the condition is key too.I would guess that someone you know has type 1 Diabetes. And more are getting diagnosed with it now than ever. I was 35 before the condition kicked in. It was an adjustment for sure. It might be something you’re aware of but don’t know a lot about. So, I was keen to talk with someone that has been not only living with it but thriving. Emma fits that description. She has been successfully managing Type 1 for over 28 years.During the conversation, we cover a lot of topics that provide a great insight into management of the Type1 Diabetes condition and how wellness, fitness and yoga can help. Of course, Yoga is not just a treatment to help with Diabetes but with every aspect of your life – mind & body!It’s definitely worth having a listen to Emma’s story and our exchanges on how we manage it, identify triggers, always have jellies or sweets nearby and all other aspects of living a life with Diabetes.Some of the topics covered:The weeks leading up to her diagnosis in 1990Getting wrongly diagnosed initiallyFailing into a Diabetic Coma for 3 days due to record high blood sugar levelsBeing very lucky that there was no organ damage after coming out of the comaHow her whole life changed once she was diagnosed as a Type1Going into denial in the weeks and months after the diagnosisLearning how to deal with the condition as a teenagerHow far technology has come in the management of diabetes in the last 28 yearsDeveloping systems for managing diabetes over the yearsNever trying to hide the fact she was a diabetic and incorporate it into her lifestyleBeing discrete with administering insulin in publicThe stigma around injections in her early years with the conditionAlways calling Diabetes a Condition not a Disease!The Mindset that Emma has – She controls it, not the other way aroundHow Diabetes has lead Emma towards a career in fitness and dietShe found Yoga as an outlet for her to really get a full workout.Yoga made Emma very aware of her skeleton, muscles and organs and how she needed to manage every part of her body!Finding out the cause and effect and how the mind can affect the body and, in her case, the diabetes controlStarting to teach Yoga and then, in 2012, setting up her own BusinessDiscussion on different types of Yoga and the benefits including:Bikram YogaYin YogaHot YogaAsthanga YogaThe battle of the Ego during Yoga practicesMeditation and YogaSleep and Hypos and how the body and mind can wake you up!The difference between Hypoglycaemic aware and unawareThe use of two types of insulin – short acting and long actingNever be complacent with the condition – always be on the watch!It’s not about winning against it, it’s about controlling it.1% Better tips around managing Diabetes & Yoga practice:Using meditation triggers like the red/stop light in traffic to bring you to the now!Meditation as a tool to help with anxietyUsing Apps like ‘calm’ to help with meditationMoving Meditation as the best form that work with EmmaYoga postures that are good for back pain issues and disc challengesRecommended frequency for Yoga sessions for runnersYoga poses that can help runners stride and paceConnect with Emma on the following:Emma teaches Yoga to a broad spectrum and it’s clear she’s very passionate about itFor Emma, it’s about making it fun and enjoyableHer approach is about finding out what her clients want to work on – being flexible to including these moves into the practicesConnect with Emma via:Website: YogawithEmma.ieTwitter: @Yoga_with_EmmaInstagram: YogawithemmaFacebook: YogawithemmaLinkedIn: Emma O'TooleJust a quick note to say thanks for listening. There are a lot of podcasts to choose from and you picking this one means a lot to me. I know that sounds like a cheese-ball thing to say, but it's true! I'm enjoying creating these shows, learning from them and I'm hoping that you are too.To help me make the show even better, I wand & need your help. Your feedback is essential. So, please take a few minutes to get in touch (links below, or subscribe on iTunes and leave a rating or review).If you liked this episode, share out the link via one of the socials. It will help me reach a bigger audience. If One Person gets something from the Episode that makes them 1% Better, I'll be a happy man.Finally, if you really love the show, and really want me to take it to the next level, I've set up a Patreon site where you pledge some financial support. That would be awesome. You will also get exclusive access to upcoming podcasts and article posts that are just for those that are Patron.Connect in with Rob on the socials or via email on:Email    Twitter   Facebook   WebsiteSubscribe to the Rob of the Green Newsletter on the website - www.robofthegreen.ie

Hi all,Welcome to the show.  It’s was my pleasure to talk with Emma O’Toole for this episode.Emma runs her own successful Yoga studio/business in Dublin, cunningly titled Yoga with Emma (www.yogawithemma.ie), and I was introduced to her through Samantha Kelly, who I interviewed near the end of Season 1. During my conversation with Samantha, the subject of Type 1 Diabetes came up as Samantha’s daughter has the condition. As I also am a Type1 Diabetic, I was interested to focus more on it in a future episode. Thanks to Samantha, Emma and I were able to make it happen.Why did I want to share this story?Since my own diagnosis, I have been learning so much about it over the last 5 years. In general, I feel it’s not a well understood condition and also can be a stigma attached to it. Education around it and the signs that it might be developing can help with an early diagnosis. Also, making others aware that someone has the condition is key too.I would guess that someone you know has type 1 Diabetes. And more are getting diagnosed with it now than ever. I was 35 before the condition kicked in. It was an adjustment for sure. It might be something you’re aware of but don’t know a lot about. So, I was keen to talk with someone that has been not only living with it but thriving. Emma fits that description. She has been successfully managing Type 1 for over 28 years.During the conversation, we cover a lot of topics that provide a great insight into management of the Type1 Diabetes condition and how wellness, fitness and yoga can help. Of course, Yoga is not just a treatment to help with Diabetes but with every aspect of your life – mind & body!It’s definitely worth having a listen to Emma’s story and our exchanges on how we manage it, identify triggers, always have jellies or sweets nearby and all other aspects of living a life with Diabetes.Some of the topics covered:The weeks leading up to her diagnosis in 1990Getting wrongly diagnosed initiallyFailing into a Diabetic Coma for 3 days due to record high blood sugar levelsBeing very lucky that there was no organ damage after coming out of the comaHow her whole life changed once she was diagnosed as a Type1Going into denial in the weeks and months after the diagnosisLearning how to deal with the condition as a teenagerHow far technology has come in the management of diabetes in the last 28 yearsDeveloping systems for managing diabetes over the yearsNever trying to hide the fact she was a diabetic and incorporate it into her lifestyleBeing discrete with administering insulin in publicThe stigma around injections in her early years with the conditionAlways calling Diabetes a Condition not a Disease!The Mindset that Emma has – She controls it, not the other way aroundHow Diabetes has lead Emma towards a career in fitness and dietShe found Yoga as an outlet for her to really get a full workout.Yoga made Emma very aware of her skeleton, muscles and organs and how she needed to manage every part of her body!Finding out the cause and effect and how the mind can affect the body and, in her case, the diabetes controlStarting to teach Yoga and then, in 2012, setting up her own BusinessDiscussion on different types of Yoga and the benefits including:Bikram YogaYin YogaHot YogaAsthanga YogaThe battle of the Ego during Yoga practicesMeditation and YogaSleep and Hypos and how the body and mind can wake you up!The difference between Hypoglycaemic aware and unawareThe use of two types of insulin – short acting and long actingNever be complacent with the condition – always be on the watch!It’s not about winning against it, it’s about controlling it.1% Better tips around managing Diabetes & Yoga practice:Using meditation triggers like the red/stop light in traffic to bring you to the now!Meditation as a tool to help with anxietyUsing Apps like ‘calm’ to help with meditationMoving Meditation as the best form that work with EmmaYoga postures that are good for back pain issues and disc challengesRecommended frequency for Yoga sessions for runnersYoga poses that can help runners stride and paceConnect with Emma on the following:Emma teaches Yoga to a broad spectrum and it’s clear she’s very passionate about itFor Emma, it’s about making it fun and enjoyableHer approach is about finding out what her clients want to work on – being flexible to including these moves into the practicesConnect with Emma via:Website: YogawithEmma.ieTwitter: @Yoga_with_EmmaInstagram: YogawithemmaFacebook: YogawithemmaLinkedIn: Emma O'TooleJust a quick note to say thanks for listening. There are a lot of podcasts to choose from and you picking this one means a lot to me. I know that sounds like a cheese-ball thing to say, but it's true! I'm enjoying creating these shows, learning from them and I'm hoping that you are too.To help me make the show even better, I wand & need your help. Your feedback is essential. So, please take a few minutes to get in touch (links below, or subscribe on iTunes and leave a rating or review).If you liked this episode, share out the link via one of the socials. It will help me reach a bigger audience. If One Person gets something from the Episode that makes them 1% Better, I'll be a happy man.Finally, if you really love the show, and really want me to take it to the next level, I've set up a Patreon site where you pledge some financial support. That would be awesome. You will also get exclusive access to upcoming podcasts and article posts that are just for those that are Patron.Connect in with Rob on the socials or via email on:Email    Twitter   Facebook   WebsiteSubscribe to the Rob of the Green Newsletter on the website - www.robofthegreen.ie

In this podcast, Tracy Herbert shares information she found while researching fasting. Should someone who needs to lose weight, lower blood pressure, have diabetes, try fasting? This podcast will provide the latest information regarding fasting.

Click here to listen to today’s Diabetes Health in the News Podcast! A new study published in the online journal Diabetes Care reports that intervention text messages can help those with type 2 diabetes improve their blood sugar levels. The study looked at Hispanic patients who were classified as low income. Dr. Addie Fortmann and her team at the Scripps Whittier Diabetes Institute tracked 126 The post Diabetes Health in The News Podcast: Text Messaging Can Help Those with Type 2 Diabetes Control Blood Sugar appeared first on Diabetes Health.

Host: Kathy King, RDN Guest: Lily Nichols Controlling blood sugar and weight gain in expectant patients with gestational diabetes can be challenging. But the move toward lower carbohydrate diets for these patients has shown promise in controlling diabetic progression through pregnancy. Joining host Kathy King to discuss the mechanisms and rationales behind this nutritional guidance is dietitian and certified diabetes educator Lily Nichols, author of Real Food for Gestational Diabetes.

Host: Kathy King, RDN Guest: Lily Nichols Controlling blood sugar and weight gain in expectant patients with gestational diabetes can be challenging. But the move toward lower carbohydrate diets for these patients has shown promise in controlling diabetic progression through pregnancy. Joining host Kathy King to discuss the mechanisms and rationales behind this nutritional guidance is dietitian and certified diabetes educator Lily Nichols, author of Real Food for Gestational Diabetes.

Host: Kathy King, RDN Guest: Lily Nichols Controlling blood sugar and weight gain in expectant patients with gestational diabetes can be challenging. But the move toward lower carbohydrate diets for these patients has shown promise in controlling diabetic progression through pregnancy. Joining host Kathy King to discuss the mechanisms and rationales behind this nutritional guidance is dietitian and certified diabetes educator Lily Nichols, author of Real Food for Gestational Diabetes.

Host: Kathy King, RDN Guest: Lily Nichols Controlling blood sugar and weight gain in expectant patients with gestational diabetes can be challenging. But the move toward lower carbohydrate diets for these patients has shown promise in controlling diabetic progression through pregnancy. Joining host Kathy King to discuss the mechanisms and rationales behind this nutritional guidance is dietitian and certified diabetes educator Lily Nichols, author of Real Food for Gestational Diabetes.

Dr. Doron Schneider and Dr. Jack Leahy discuss the Diabetes Control and Complications Trial and the follow up study, EDIC. These landmark, studies performed 30 years ago, have stood the test of time and still influences the standard of care today.

Dr. Doron Schneider and Dr. Jack Leahy discuss The Diabetes and Complications Trial, a landmark study that still influences the standard of diabetes patient care. 

 Dr. Schneider and Dr. Leahy discuss EDIC, the follow up study to The Diabetes Control and Complications trial.

 Dr. Doron Schneider and Dr. Jack Leahy discuss what The Diabetes Control and Complications discovered about weight issues and the Diabetic patient.

Host: Farhad Zangeneh, MD Guest: Paul Jellinger In diabetes management, clinicians typically measure glycemic control with fasting plasma glucose (FPG) and premeal glucose measurements, and HbA1c. And, the goals for each of these measurements have been established based on the results of many clinical trials. However, the majority of patients with diabetes fail to achieve these glycemic goals. Elevated postprandial glucose (PPG) concentrations may contribute to suboptimal glycemic control. Host Dr Farhad Zangeneh is joined by Dr. Paul Jellinger who will address the issue of postprandial glucose and its complications. Paul S. Jellinger, MD and Master of the American College of Endocrinology (MACE) serves as Professor of Medicine on the voluntary faculty at the University of Miami and served as Chief of the Section of Endocrinology at Memorial Regional Hospital in Hollywood, Florida. Dr. Jellinger served as president of the AACE, the ACE and the Florida Endocrine Society. Dr. Jellinger has been active on the AACE Board of Directors.

Guest: Sandra Bourdette Host: Steven Edelman, MD The results of the landmark Diabetes Control and Complications Trial proved that intensive management of diabetes can significantly improve diabetes outcomes. The education of both the healthcare professional and patient is a key component in the successful management of diabetes. Join host Dr. Steven Edelman and his guest, executive director of Taking Control of Your Diabetes (TCOYD), Sandra Bourdette, as they discuss the mission and results of their novel approach to diabetes education.

Guest: Denise L. Faustman, MD Host: Bruce Bloom, DDS, JD Type 1 diabetes affects over 1 million Americans and costs billions of dollars every year. Dr. Denise L. Faustman, director of the Immunobiology Laboratories at the Massachusetts General Hospital in Boston, discusses with host Dr. Bruce Bloom her cure research and the possibility of a generic drug cure.